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ABSTRACT
A NOVEL APPROACH TO INCREASE UPPER EXTREMITY
ACTIVE RANGE OF MOTION FOR INDIVIDUALS WITH DUCHENNE
MUSCULAR DYSTROPHY USING ADMITTANCE CONTROL
by
Madeline Corrigan
Duchenne muscular dystrophy (DMD), a neuromuscular disease with a prevalence of 1 in
3,500-5,000 male births, results in progressive muscle weakness causing loss of
independence and imposing the demands of costly and intrusive assistive support and
personal care for daily living tasks. Upper extremity function begins to decline while
ambulation is still possible and gradually progresses with time, playing a prominent role
in loss of independence. Importantly, upper extremity functional limitations exist despite
residual muscle strength that is insufficient to lift the arms against gravity. Presently,
there exist a number of commercially available assistive devices aimed at augmenting
upper extremity functional deficit; however, these devices have been largely unsuccessful
in delivering the independence they seek to provide. Passive orthoses, the most common
of these commercially available assistive devices, are limited to those in the earlier stages
of functional loss because of the imperfect gravity compensation, requirement of
sufficient muscle strength to overcome the inertia of the device, and inability to
accommodate loss of strength over time. The objective of this project is to overcome the
limitations of currently available upper extremity assistive devices for individuals with
DMD by using admittance control. Admittance control is an inherently safe and intuitive
robotic control paradigm that maps the user’s applied force to the motion of a robot. It is
hypothesized that a motorized arm support utilizing the admittance control paradigm will

provide individuals with DMD an intuitive and effective means of increasing upper
extremity AROM and independence through the use of their residual muscle strength.
The results of this project demonstrate that individuals with DMD who have
limited or nonexistent upper extremity function retain residual muscle strength sufficient
to generate voluntary movement when the arms are supported against gravity.
Furthermore, the results show that admittance control allows for the use of this residual
strength to increase the AROM of individuals with DMD to a greater degree than a
commercially available passive arm support and provide increased independence in the
performance of user-defined priority tasks compared to unsupported movements. The
results also show that over one year there is no significant decrease in the AROM
provided by the admittance control robot, indicating the viability of an admittance control
motorized arm support to provide sustainable improvements in upper extremity function
in the presence of progressive muscle loss. Finally, two prototypes are presented that
demonstrate a novel approach to upper extremity exoskeleton design.

The phase 1

prototype establishes the successful implementation of admittance control as the control
paradigm for fully motorizing all degrees of freedom (DOF) of a commercially available
passive arm support. The phase 2 prototype demonstrates a modular approach intended
to accommodate changes in upper extremity function over time through the successful
implementation of one motorized DOF of a commercially available passive arm support
while keeping the other DOFs passive. The work presented herein is a comprehensive
investigation to establish the benefits of admittance control to increase upper extremity
AROM and improve independence for individuals with DMD with the intention of
allowing these individuals to maintain optimal quality of life.
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CHAPTER 1
INTRODUCTION

1.1 Motivation
Progressive muscle weakness characteristic of Duchenne muscular dystrophy (DMD)
results in loss of upper extremity function and reduction of independence in activities of
daily living over time. For individuals with DMD, maintaining optimal quality of life
depends largely on the preservation of self-sufficiency. It follows that an assistive device
that can augment lost upper extremity function by providing increase voluntary
movement has the potential to improve quality of life for these individuals. However,
current commercially available upper extremity assistive devices fail to deliver the
independence they seek to provide. Establishing the feasibility of using an admittance
control robot to allow very small muscle forces to control upper extremity movements
has the potential to significantly advance the field of upper extremity assistive devices for
individuals with DMD. Even more, fabricating an upper extremity arm support that
utilizes the benefits of admittance control has the potential to increase independence and
overall quality of life for individuals with DMD.

1.2 Objective
The objective of this project is to overcome the limitations of currently available upper
extremity assistive devices for individuals with DMD by using admittance control.
Admittance control is an inherently safe and intuitive robotic control paradigm that maps
the user’s applied force to the motion of a robot. The use of admittance control provides
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a means to balance the arm against gravity more precisely, minimize friction, and reduce
inertia, thereby decreasing the overall force required by the user to generate a movement
compared to that required by a passive arm support. It is hypothesized that a motorized
arm support utilizing the admittance control paradigm will provide individuals with
DMD an intuitive and effective means of increasing upper extremity AROM through the
use of their residual muscle strength.

1.3 Specific Aims and Hypotheses
1.3.1

Specific Aim 1

Specific Aim 1: Validate the anecdotally reported observations of residual upper
extremity muscle strength of individuals with DMD who have limited or nonexistent
upper extremity function. The increase in upper extremity AROM of individuals with
DMD when the arms are supported in the water compared to unsupported movements is a
widely accepted clinical observation and a principle that is utilized in the design of
passive orthoses; however, it has yet to be validated or quantified in a research setting.
The objective of this aim is to validate the anecdotally reported observations that
individuals with DMD who have limited or nonexistent upper extremity function have
residual muscle strength sufficient to generate voluntary movement when the arms are
supported against gravity.
Sub Aim 1.1: Investigate the degree of change in upper extremity AROM of an
individual with DMD when the arms are supported against gravity compared to
unsupported movements in a case study. The objective of this sub-aim is to quantify the
degree of change in upper extremity AROM of shoulder and elbow movements while the
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arms are supported against gravity in the water compared to when the arms are not
supported. It is hypothesized that the AROM of shoulder and elbow movements will be
greater when the arms are supported against gravity in the water compared to when the
arms are not supported.
Sub Aim 1.2: Investigate the degree of upper extremity AROM of an individual
with DMD when the arms are supported against gravity compared to unsupported
movements in a longitudinal case study. The objective of this sub-aim is to track the
changes in upper extremity AROM when the arms are supported in water over the course
of 19 months, beginning during ambulation and continuing after ambulation is lost,
compared to the upper extremity AROM while unsupported. It is hypothesized that prior
to loss of ambulation water-supported and unsupported AROM will be similar; and, the
unsupported AROM will decrease over time at a faster rate than water-supported AROM.
Furthermore, it is hypothesized that there will be a larger difference between unsupported
and water-supported AROM after ambulation is lost.
1.3.2

Specific Aim 2

Specific Aim 2: Examine the feasibility of using an admittance control motorized arm
support to increase the upper extremity AROM of individuals with DMD to a greater
degree than that provided by a passive arm support. Current commercially available arm
supports provide increased AROM for individuals with DMD by providing support
against gravity and reducing friction. However, these devices are limited by their inexact
gravity compensation and their inability to reduce inertia. The HapticMASTER, a 3
degrees of freedom (DOF) admittance control robot, provides more exact gravity
compensation while minimizing friction and reducing inertia. The objective of this aim is
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to examine the upper extremity AROM provided by the HapticMASTER robot compared
to the Armon Edero, a commercially available passive arm support, in a single session
and in a longitudinal study.
Sub Aim 2.1: Investigate the degree of upper extremity AROM associated with the
use of an admittance control motorized arm support compared to that associated with the
use of a passive arm support by individuals with DMD. The objective of this sub-aim is
to quantify the upper extremity AROM for a standardized set of movements while the
arms are supported by the HapticMASTER admittance control robot compared to while
the arms are supported by the Armon Edero commercially available passive arm support.
It is hypothesized that the upper extremity AROM of individuals with DMD will be
greater when supported by the HapticMASTER robot compared to the Armon Edero.
Sub-Aim 2.2: Investigate the degree of upper extremity AROM associated with the
use of an admittance control motorized arm support compared to that associated with the
use of a passive arm support by individuals with DMD in a longitudinal study. The
objective of this sub-aim is to track the changes in upper extremity AROM when the
arms are supported by the HapticMASTER in three sessions over the course of one year
and compare that to the upper extremity AROM while supported by the Armon Edero
over the same period of time. It is hypothesized that Armon Edero supported AROM will
decrease over time at a faster rate than HapticMASTER supported AROM.
1.3.3

Specific Aim 3

Specific Aim 3: Examine the feasibility of using an admittance control motorized arm
support to increase independence in activities of daily living for individuals with DMD.
The success of an upper extremity assistive device relies heavily on the ability of the
4

device to meet needs defined by the user. The objective of this aim is to examine the
feasibility of using an admittance control motorized arm support to provide an increase in
independence in activities of daily living specified by each user based on their individual
needs compared to the performance of the same activities while unsupported.
Sub Aim 3.1: Identify the upper extremity priority tasks of individuals with DMD
who have limited upper extremity function. The objective of this sub-aim is to identify
user-defined upper extremity priority tasks based on tasks that individuals with DMD
cannot perform or have difficulty performing independently due to upper extremity
functional deficits and would consider most important to be able to perform while using
an upper extremity assistive device. It is hypothesized that upper extremity priority tasks
of individuals with DMD will include activities of daily living relating to eating,
drinking, personal care, and hygiene and hobbies specific to each individual’s interests.
Sub Aim 3.2: Evaluate the use of an admittance control motorized arm support to
increase independence in the performance of upper extremity priority tasks for
individuals with DMD. Users will be asked to perform their priority tasks while their
dominant arm is unsupported and again while the dominant arm is supported by the
HapticMASTER robot. The objective of this sub-aim is for users to evaluate these
experiences in order to determine whether the use of an admittance control motorized
arm support will allow for improvements in independence while performing priority
tasks. It is hypothesized that the use of an admittance control motorized arm support will
allow for an increase in independence of priority tasks compared to when the arms are
unsupported.

5

1.3.4

Specific Aim 4

Specific Aim 4: Design a prototype of an admittance control motorized arm support. The
HapticMASTER robot, used to test admittance control in aims 2 and 3, is an expensive,
large, non-portable means of providing increased AROM for individuals with DMD, and
is limited to only 3 translational DOFs. For these reasons, the HapticMASTER is a
research robot that can be used to test the benefits of admittance control in a laboratory
setting but would not be practical as an assistive device for activities of daily living in the
home and community. The objective of this aim is to build a prototype demonstrating the
ability to fabricate an admittance control motorized arm support for the purpose of being
used by individuals with DMD in the home and community.
Sub Aim 4.1: Design a fully motorized, multi-DOF proof-of-concept prototype of
an admittance motorized arm support. The objective of this sub aim is to fabricate a
fully functional, multi-DOF motorized arm support that operates under the admittance
control paradigm.
Sub Aim 4.2: Design a modular admittance control arm support. The objective of
this sub aim is to fabricate a fully functional arm support that implements admittance
control modularly in a single DOF while other DOFs remain passive.
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CHAPTER 2
BACKGROUND

2.1 Duchenne Muscular Dystrophy (DMD)
Muscular dystrophy is a group of disorders that greatly limit an individual’s ability to use
their muscles.

Duchenne muscular dystrophy (DMD), the most common type of

muscular dystrophy, is an X-linked recessive neuromuscular disorder with an incidence
of 1 in 3,500-5,000 male births [1]. It is characterized by near or total lack of the protein
dystrophin, which provides structural stability to the dystrophin-associated protein
complex in the cell membrane of muscle cells [2, 3]. The absence of dystrophin in the
muscle cell membrane results in the five mechanisms of DMD pathophysiology, which
are: the mechanical weakening of the sarcolemma (the cell membrane of a muscle cell),
inappropriate Ca2+ influx (which is involved in skeletal muscle contraction), aberrant
cell signaling, increased oxidative stress, and recurrent muscle ischemia (restricted blood
supply) [4]. These mechanisms directly result in the progressive weakening of skeletal,
respiratory, and cardiac muscles causing decreased independence and shortened life
expectancy [3].
The onset of muscle weakness in children with DMD characteristically occurs
before 5 years of age. This is soon followed by gait difficulty and an eventual loss of
ambulation occurring most often during the teenage years. At this time, individuals with
DMD are fully dependent on a wheelchair. Chronic respiratory failure develops in the
advanced stages of the disease and death occurs, on average, at the age of 25 [2, 5].
Figure 2.1 shows the results of an investigation by Kohler et al. demonstrating the change
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in physical disability with age in 29 patients with DMD. The results clearly demonstrate
that DMD presents progressive limitations in activities of daily living and dependence on
personal care and technical aids as a result of progressive muscle loss [5].

Figure 2.1 Disability scores of 29 individuals with DMD obtained from a longitudinal
study demonstrating a progressive decrease in independence. Higher physical disability
scores reflect greater dependence on personal and technical aids and limitations in
activities of daily living.
Source: [5]

The administration of mechanical ventilation is commonplace when patients
begin to exhibit respiratory failure. Its application is responsible for increasing the
median survival rate for individuals with DMD beyond 25 years.

Even more,

noninvasive ventilation and mechanically assisted coughing have been shown to
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significantly prolong survival [6].

Other treatments, such as steroids for muscle and

cardiac function, slow the progression and increase the life expectancy of individuals
with DMD. There are also a number of experimental drug therapies being developed and
tested including Eteplirsen, an exon skipping drug that received accelerated approval
from the US Food and Drug Administration in September 2016. Eteplirsen also aims to
slow the progression of DMD and extend life expectancy [1]. However, despite the
advancements in steroid treatments, respiratory aids, and drug therapies, there remains no
cure for DMD [2, 3, 7].

These therapies that slow progression and increase life

expectancy result in a significant portion of the population of individuals with DMD
living with a strong dependency on personal and technical care and support.

2.2 Upper Extremity Functional Loss in DMD
Upper extremity functional assessment studies show progressive upper extremity
weakness in individuals with DMD. The onset of upper extremity weakness occurs
during ambulation and gradually increases with time in a proximal to distal gradient. A
study by Jung et al. aimed to correlate the progressive upper extremity functional loss in
individuals with DMD with age. The study involved the evaluation of upper extremity
function using the Brooke scale. The Brooke scale consists of ratings between 1 and 6,
with 1 reflecting full upper extremity functionality and 6 representing no useful function
of the upper extremities. Table 2.1 shows the grading for the Brooke scale. Figure 2.2
shows a plot of the Brooke scale scores from 90 individuals with DMD collected in up to
three separate sessions plotted versus age. The results of this study demonstrate a linear
decrease in upper extremity function in individuals with DMD with age [2, 7, 8].
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Table 2.1 Grading for the Brooke Scale for Upper Extremity Function
Grade Functional Description
Starting with arms at the sides, the patient can abduct the arms in a full circle
1
until they touch the head
Can raise arms above head only by flexing the elbow (shortening the
2
circumference of the movement) or using accessory muscles
Cannot raise hands above head, but can raise an 8-oz glass of water to the mouth
3
Can raise hands to the mouth, but cannot raise an 8-oz glass of water to the
4
mouth
Cannot raise hands to the mouth, but can use hands to hold a pen or pick up
5
pennies from the table
Cannot raise hands to the mouth and has no useful function of hands
6
Source: [2]

Figure 2.2 The Brooke scale score of individuals with DMD plotted versus age.
Source: [2]

The impact of loss of upper extremity function in individuals with DMD is further
emphasized by the decline in reachable surface area as the muscles atrophy over time.
Figure 2.3 shows a three dimensional plot of the reachable surface area, a measure of
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active range of motion (AROM) using the reachable surface evaluation [9], of a nonambulatory individual with DMD compared to the reachable surface area of an individual
without DMD. The plots demonstrate the upper extremity functional deficit experienced
by individuals with DMD [9].

Figure 2.3 Results of the upper extremity reachable workspace evaluation of an
individual with DMD (bottom) and control subject (top).
Source: [9]
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The loss of upper extremity muscle strength and AROM in individuals with DMD
is especially detrimental to self-sufficiency because of the correlation between upper
extremity function and independently performing activities of daily living. Furthermore,
a number of studies note that upper extremity function deserves more attention in
rehabilitation and research because of its association with independence for individuals
with DMD [3]. The importance of independence lies not only in providing selfsufficiency and improved quality of life, but also boasts the advantage of significantly
decreasing the financial burden associated with personal care required for those with
limited independence [10, 11]. These points underscore the need for assistive technology
that can lessen the impact of limited and continually decreasing upper extremity function
on independence, finances, and quality of life.
Loss of upper extremity function in individuals with DMD is not only due to
muscle weakness resulting from the disease itself. Additional contributing factors to the
loss of upper extremity function in individuals with DMD are disuse atrophy and the
development of contractures. Disuse atrophy is the secondary deterioration of muscle
strength that results from a person’s actual performance despite a greater potential
capacity. Because loss of muscle strength leads to a more sedentary lifestyle, especially
for those who are non-ambulatory and cannot lift their arms against gravity, disuse
atrophy accelerates functional loss. Even more, decreased activity leads to increased fat
mass, making movements more difficult under the added weight, and further
exacerbating the problem of progressive loss of strength due to disuse. It is widely
accepted among clinicians that the regular use of residual muscle strength through sub-
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maximal exercise has the potential to lessen or prevent disuse atrophy in individuals with
DMD [12, 13].
An additional secondary complication resulting from the progressive loss of
muscle strength and further contributing to loss of function is the development of
contractures. Contractures are the loss of joint motion due to tightening of muscle,
tendons, and ligaments. The result is a decrease in reachable workspace as the muscle can
no longer stretch sufficiently to allow the joint to achieve its maximum angular range.
Furthermore, the force generated by a muscle is a factor of the length at which the muscle
contracts. Therefore, if a muscle is held in a shortened position, as is the case with
contractures, it will be further weakened. Moreover, contractures cause discomfort, so it
is typically recommended that preventing them not only allows for increased
functionality but also improves postural symmetry and comfort while sitting.

The

development of contractures is correlated with the onset of wheelchair use and increases
with time thereafter. Typical physical therapy interventions administered to individuals
with DMD to prevent contractures include active, active-assisted, or passive stretching.
However, these physical therapy interventions typically fall short as they require
sufficient time and training and regular compliance by the individual [14-6].
In the presence of primary muscle weakness, any further secondary loss of muscle
strength should be avoided at all costs [15]. Therefore, disuse atrophy and contractures
should be prevented whenever possible. Unfortunately, there are a number of barriers
that inhibit compliance with these recommendations including lack of time, feeling
overwhelmed by prescribed exercise and stretches, limited access to physical therapy,
and the unfamiliarity of some physical therapists with DMD. Consequently, despite these
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recommendations, there often remains a lack of implementation of these measures to
prevent the secondary deterioration of function [15, 16]. As a result, these secondary
contributions accelerate functional loss, further emphasizing the need for assistive
technology that can effectively provide increased upper extremity function.

2.3 Upper Extremity Assistive Devices for Individuals with DMD
Currently there exist a number of assistive devices aimed at augmenting upper extremity
functional deficit for individuals with DMD. However, few of these devices are widely
used by individuals with DMD and all have been largely unsuccessful in delivering the
independence they seek to provide [17, 18]. Current state of the art upper extremity
assistive devices for individuals with DMD fall into one of three categories: passive
orthoses, active orthoses, and robotic manipulators.
2.3.1

Passive Orthoses

The Balanced Forearm Orthosis (BFO), also known as the mobile arm support, is a
passive device, meaning that it is powered by the body. Developed in 1965, the BFO
allows movement in the horizontal plane for individuals with weak musculature, such as
individuals with DMD [19]. Enhanced version of the BFO have since been developed
that support the arm against gravity using springs or rubber bands to allow for both
horizontal and vertical movements. The Armon Edero by Armon Products and the X-Ar
by Talem Technologies, shown in Figure 2.4, are two examples of commercially
available passive arm supports.

These devices support the arm against gravity by

adjusting the length of a spring [20, 21]. Similarly, the Wilmington robotic exoskeleton
(WREX) is a commercially available wheelchair mountable, passive arm orthosis that
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balances the user’s arm against gravity using rubber bands [22]. Gravity compensation
allows individuals with DMD, who could not otherwise raise their arm against gravity,
attain increased AROM.

These non-powered devices are preferred to powered devices

in many cases because they utilize the residual strength and natural control that is still
present. However, passive arm supports are limited to those in the earlier stages of
functional loss because of their imperfect gravity compensation. The springs or rubber
bands utilized by passive arm supports provide the user support against gravity lifting the
arm to a set-point resulting in a non-constant upward vertical force to counterbalance
gravity. Therefore, lowering the arm against the force of the spring or rubber bands or
raising the arm against gravity requires a substantial degree of muscle strength. As a
result, these devices are limited to individuals with DMD who are in the early stages of
functional loss because progressive muscle loss will eventually limit AROM to the
horizontal plane. Additionally, passive arm supports reduce friction but still require
sufficient strength from the user to overcome the inertia of their arm and the device in
order to generate a movement. The friction and inertia opposing the user’s movements
are constant and cannot be adjusted as the user’s muscle strength changes over time. So,
the friction and inertia opposing the user’s movements will eventually limit the AROM
provided by the device as muscle strength decreases over time. These devices also
require full functionality and strength of their hands and wrists for the user to be able to
interact with their environment. And, if such functionality remains, any interaction the
user has with their environment will cause the gravity compensation to become
unbalanced, rendering the device useless [19, 23-26]. As a result, the use of passive arm
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supports by individuals with DMD is limited due to their inability to significantly restore
functionality for a sustained period of time.

Figure 2.4 The X-Ar passive arm support (top) and the Armon Edero passive arm
support (bottom).
Source: [20, 21]

There have been devices that aim to overcome the limitation of mobile arm
supports in which gravity compensation becomes unbalanced when the user picks up an
object. Herder et al. developed a mobile arm support, pictured in Figure 2.5, that allows
the user to initiate electronic adjustments to the gravity balancing force whenever they
pick up an object [25]. Similarly, Daniel, et al. added an electronic component to the
WREX, a passive device not originally designed to accommodate a varying load, that
allows for dynamic gravity compensation [22]. These devices have been shown to
successfully increase the upper extremity AROM of individuals with DMD, even in the
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presence of a varying load.

However, they require the user to adjust the gravity

balancing force with switches or buttons whenever an object is picked up. This is
cumbersome, non-intuitive, and requires the input of additional energy. In addition, these
devices retain the limitations of other passive arm supports in that they require the user to
have full hand and wrist function and remain limited to individuals in the earlier stages of
functional loss [24, 27].

Figure 2.5 Prototype arm support developed by Herder et al. that allows electronic
adjustment of the gravity balancing force.
Source: [25]

2.3.2

Active Orthoses

Active orthoses, also known as dynamic arm supports, are exoskeletons that support and
direct the arm through the use of control inputs in order to perform activities of daily
living. These devices, such as the ARMin pictured in Figure 2.6, a six DOF exoskeleton,
have the potential to augment muscle capacity and allow increased joint range of motion
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for individuals with DMD [28]. Additionally, if an orthosis is made available in the early
stages of the disease, it has been suggested that the user will maintain a larger range of
motion over the course of progression because of the prevention of contractures.
Unfortunately, as is the case with passive orthoses, these devices require the user to have
full use of their hand, wrist, and fingers for the device to allow independent performance
of activities of daily living. Further limitations of exoskeletons include their large size,
non-portability, substantial weight, power consumption, and the fact that functionality is
generally overshadowed by the cumbersome nature of the devices and ultimate burden on
the user.

The position and orientation of most powered orthoses are controlled by

switches or joysticks operated by the user’s contralateral hand, head, or tongue. These
control schemes are not intuitive because they involve mapping a one or two DOF control
to a six DOF robot which will require operating modes and training. This results in
significantly increased execution time for simple movements. Additionally, joysticks and
switches are not well suited for individuals in the later stages of functional loss because
they require the user to grasp the device for long periods of time which can result in
fatigue [17, 19, 28-31].
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Figure 2.6 The ARMin active orthosis.
Source: [28]

2.3.3

Robotic Manipulators

Robotic manipulators perform tasks that require reaching and grasping to assist
individuals with decreased arm strength, such as individuals with DMD, in order to allow
independence in activities of daily living in the home, community, and employment
settings. The intelligent Assistive Robotic Manipulator (iARM), commercially available
from Exact Dyanmics, B.V. of The Netherlands, is a wheelchair mountable, six DOF
assistive robot with a gripper that allows individuals with impaired arm function to
perform a range of activities such as eating, drinking, brushing teeth, scratching, and even
delicate tasks such as handling a DVD or USB stick, painting, and putting in earrings.
The iARM, pictured in Figure 2.7, uses interfaces such as a keypad, joystick, or single
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switch to allow the user to control its movement [32, 33]. The Teachmover manipulator
from Microbot Inc., Mountain View, CA, is a similar wheelchair mountable assistive
robot that has been commercially available for over 22 years. Similar to the iARM, it is
powered with a 12-V wheelchair battery. The interface to the Teachmover manipulator is
a multi-button touchpad. However, the interface can be changed based on the capabilities
of the user, as was demonstrated in a study by Shramowiat et al., in which the interface
was altered to use two toggle switches [34]. Similar studies performed by Bach et al.
integrated both touch sensitive and toggle switch user interfaces for two six DOF robots
with grippers: the Cobra RS2 manipulator by Cobra, Darmstadt, West Germany and the
Microbot 453-H manipulator by Movemaster, Mountain View, CA [35]. All of these
robotic manipulators have resulted in an improved initiative and sense of independence in
activities of daily living and decreased dependence on personal care attendants for
individuals with DMD. In addition, the cost of a robotic manipulator can be offset by the
decrease in personal care costs [34, 35]. Even so, the progressive muscle weakness that
is present in individuals with DMD impairs hand and wrist function that are essential for
using button, joystick, and switch interfaces [36].
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Figure 2.7 The intelligent Assistive Robot Manipulator (iARM).
Source: [33]

Fortunately, the majority of robotic manipulators allow for the integration of userspecific interfaces such as chin or head-position control, sip-and-puff switches, and voice
control that eliminate the need for hand and wrist strength to control the device [34].
However, the development of user-specific interfaces to accommodate functional
variations requires the time-consuming and costly work of a professional [34].
Furthermore, all of these control schemes are non-intuitive and therefore require
operating modes and training [17]. The adequacy of a robotic manipulator is likely to be
evaluated based on the time it takes to complete a task using the robot compared to time
it takes a personal care attendant to perform the same task. To that point, it has been
found that the majority of interfaces currently implemented with robotic manipulators
require a significant amount of time to complete a task and frequently overshoot the
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target, rendering them insufficient for frequent use for activities of daily living [17, 18,
34, 35].
Despite all of the advancements and variety of approaches to augmenting upper
extremity function, there remains no upper extremity assistive device that is widely
accepted by individuals with DMD. Current prototypes and commercially available
devices are largely unsuccessful in allowing the independence for activities of daily
living that they seek to provide.

2.4 Antigravity Assistance to Increase AROM
The progressive loss of upper extremity strength in individuals with DMD eventually
limits a person’s ability to lift their arms against gravity causing movements to be limited
to just the hand and wrist and eventually limited to just the fingers. Once an individual
can no longer lift their arms against gravity their ability to independently perform actives
of daily living is severely diminished. However, it is of great importance to note that
though upper extremity movement is limited at this stage of functional loss, residual
muscle strength does exist [4, 7].
The observation of remaining muscle strength following the loss of antigravity
muscle strength is demonstrated in aquatic therapy for individuals with DMD. As the
human body is immersed in water, water is displaced which results in the force of
buoyancy.

This force of buoyancy is opposite the force of gravity and therefore

decreases joint loading forces on the joints that are immersed. It is a widely accepted
qualitative assessment that individuals with DMD have an increased degree of freedom of
movement when they are provided with antigravity assistance in the form of buoyancy.
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Furthermore, multiple studies have anecdotally reported that the buoyancy of water
enables independent initiation of movements for individuals with DMD that are less
likely when the person is on land [37-40]. These observations have been the basis for
assistive technology that can provide similar support against gravity to increase AROM.
Passive orthotic devices for individuals with DMD provide assistance against gravity
using springs or rubber bands. Despite the fact that these devices restore functionality to
only a limited extent, they have been shown to allow those with limited antigravity
strength significantly increased AROM [19, 23-26].
Once antigravity strength is lost, use of the arms for activities of daily living is
hindered. Disuse of residual strength causes secondary disuse atrophy which hastens the
deterioration of the upper extremity muscles. And, because the arms are no longer being
utilized, the joints are no longer being moved regularly through their full range of motion
which will ultimately lead to the development of contractures.

As was previously

mentioned, both disuse atrophy and contracture development will accelerate functional
loss of the upper extremities. For this reason, when the arms can no longer be lifted
against gravity, secondary disuse atrophy and contracture development become
quintessential contributors to upper extremity functional loss [12-16]. Though exercise
and active stretching are the best methods for preventing disuse atrophy and contractures,
once an individual with DMD cannot lift their arms against gravity both exercise and
active stretching are not possible [13, 19, 24-26].
A well designed assistive device will employ antigravity support as it provides a
potential means for individuals with DMD to utilize their residual strength for increase
independence in activities of daily living. Furthermore, a device that promotes the use of
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residual muscle strength has the potential to reduce disuse atrophy and the development
of contractures, introducing the potential of delaying functional loss to some degree with
regular use of the device.

2.5 Admittance Control
Admittance control, though not routinely used in conventional robots, is a robotic control
paradigm that maps the user’s applied force to the motion of a robot using Equation 2.1.
The acceleration of the robot (x’’(t))

is determined by the rate at which a small,

frictionless, virtual point mass (m) would accelerate under the user’s applied force (F(x))
and specified damping (b) [41]. As a result, friction and inertia are minimized. The
inertia of the small virtual point mass, which can be specified based on the capabilities of
the user and adjusted as those capabilities change over time, and the specified damping
are the only things opposing the user’s movements. Therefore, the overall force required
by the user to generate a movement is decreased compared to passive arm supports, as
these devices only decrease friction and not inertia.

Admittance control allows for

proportional, compliant control because it mimics passivity which makes it inherently
safe and intuitive. Additionally, it provides a means to introduce motorized antigravity
assistance in order to increase the AROM of the user.

Antigravity assistance is

incorporated by including a vertical force equal and opposite to the force of gravity acting
on the user’s arm in the admittance control equation. This antigravity assistance is more
precise than that provided by passive arm supports that use springs or rubber bands to
support the arm as it is a constant upward force calibrated to the force of gravity acting
on the user’s arm [41, 42]. Because of the advantages of admittance control, it is well
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suited for use by individuals with limited muscle strength as it allows for the use of
residual muscle strength to intuitively control the motion of a powerful robot without the
requirement of strength sufficient to overcome gravity and the friction and inertia of the
robot. Also, any force encountered by an admittance control robot will not oppose the
user’s movements. Because an admittance control robot promotes the use of residual
muscle strength and active stretching of the joints and muscles it may have the potential
to reduce disuse atrophy and the development of contractures that further contribute to
upper extremity functional loss.
(2.1)

The HapticMASTER (Moog FCS Control Systems, The Netherlands) is a highperformance admittance control robot used in research studies to assess the effectiveness
of admittance control and gravity compensation in rehabilitation. The HapticMASTER is
a commercially available 3 DOF robot with low level inertial properties, allowing use by
individuals with various levels of impairment [42, 43].

A study by Sukal et al.

investigated upper extremity discoordination following hemiparetic stroke using the
HapticMASTER as a tool to support the arms against gravity. The support provided
against gravity and the minimization of inertia and friction allowed for use in
rehabilitation with individuals post stroke as these individuals exhibit weakness and
discoordination. The results from this study demonstrated a greater reachable workspace
when the arm is fully supported against gravity using the HapticMASTER robot
compared to unsupported or partially supported movements [43]. A similar study by
Bastiaens et al. evaluated the AROM of individuals with multiple sclerosis with severe
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arm dysfunction while supported by the HapticMASTER robot against gravity.
Similarly, the results of this study demonstrated greater reachable workspace while
supported by the HapticMASTER robot [44]. These studies demonstrate the usefulness
of admittance control as a tool to allow individuals with limited upper extremity function
increased AROM.
Lobo-Prat, et al. from the Flextension Foundation of the Netherlands Organization
for Scientific Research has explored the use of admittance control for individuals with
DMD.

Feasibility studies have shown that an admittance control device allowed

individuals with DMD to perform voluntary movements that they otherwise could not
perform when unsupported [45].

However, the proposed device requires alignment

between the motor axis and the elbow joint, a design in which misalignment can cause
discomfort. Even more, the design requires increased complexity in the control system
given the need to distinguish between the user’s voluntary movements and gravity which
is pose dependent. As a result, the authors state that a multi-DOF version of the device
may be too cumbersome and not allow for gravity compensation. The authors also
propose a combination system that involves force-based control and EMG for individuals
with DMD [45].
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CHAPTER 3
AIM 1: RESIDUAL UPPER EXTREMITY STRENGTH

3.1 Sub Aim 1.1 Methods
The objective of this sub aim was to quantify the degree of change in upper extremity
AROM of an individual with DMD when the arms are supported against gravity
compared to unsupported movements.

The degree of voluntary movement was

determined for shoulder and elbow movements while the arms were unsupported and
while the arms were supported against gravity in water.
The subject for this sub aim was recruited though the Muscular Dystrophy
Association. The subject was included in the study based on the following inclusion
criteria: DMD diagnosis, cannot raise hands to mouth unassisted but has some residual
hand function (Brooke Scale score of 5), regular participation in aquatic therapy (to
ensure safety and comfort in the pool), and no presence of comorbidities affecting the
upper extremities. The subject was instructed to perform five movements to the best of
his ability: horizontal shoulder abduction and adduction while upright, shoulder
abduction while supine, and elbow flexion and extension. Shoulder adduction while
supine was not collected because the subject could not achieve the supine position for this
movement while out of the water due to equipment restrictions preventing the movement
from being conducted in the gravity-eliminated position. Each movement was performed
with the left and right arms in two conditions: (1) outside a pool where the arms are
unsupported and (2) in a pool while the arms are supported by the water. The AROM of
each movement was recorded using a plastic universal goniometer with the AROM angle
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measured in degrees from the start position to the end of voluntary movement. The
AROM difference scores were calculated by subtracting the unsupported AROM angles
from the water-supported AROM angles for each movement. The primary outcome
measure for this study is the AROM angle of each of the five movements in the water and
out of the water. The subject’s body, with the exception of the arms, was supported as
needed by an aquatic therapist while in the water. The portion of the study conducted in
the water took place in an accessible, warm-water therapy pool. Figure 3.1 shows an
example of the protocol with the subject.

Figure 3.1 A subject with DMD performing the upright horizontal adduction movement
with the left arm out of the water (left) and in the water (right).
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3.2 Sub Aim 1.1 Expected Results
Due to the progressive nature of DMD and the requirement of sufficient muscle strength
to lift the arm against gravity, it is expected that all AROM angles will be larger for the
movements executed while the arms are supported against gravity in the water compared
to unsupported movements.

3.3 Sub Aim 1.1 Results
Table 3.1 shows the unsupported AROM angles, the AROM angles in the water, and the
difference scores for one subject with DMD for the left and right arms. The watersupported AROM was larger for all 5 movements for the left and the right arm compared
to unsupported movements. The left arm had a mean increase in AROM of 35 degrees
for water-supported movements compared to unsupported movements. The right arm had
a mean increase in AROM of 49.7 degrees for water-supported movements compared to
unsupported movements. Horizontal elbow flexion and horizontal elbow extension had
the smallest increase in AROM for water-supported movements compared to unsupported
movements for the left and right arm. Horizontal abduction had the largest increase in
AROM for water-supported movements compared to unsupported movements for the left
and right arm.
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Table 3.1 Unsupported and Water-Supported AROM Results
AROM Out of
Water
Left
Right

Left

Right

Left

Right

36.0°

11.0°

91.0°

98.5°

55.0°

87.5°

21.5°

36.0°

70.5°

89.0°

49.0°

53.0°

35.0°

40.0°

72.5°

96.0°

37.5°

56.0°

70.5°
Horizontal
Elbow Flexion
86.0°
Horizontal
Elbow Extension

50.0°

89.0°

88.0°

18.5°

38.0°

87.0°

101.0°

101.0°

15.0°

14.0°

Movement

Horizontal
Abduction
Horizontal
Adduction
Abduction

AROM In Water

Difference Scores

3.4 Sub Aim 1.1 Discussion
The results from this case study support the hypothesis that individuals with DMD have
increased AROM when the arms are supported against gravity.

This indicates that

individuals with DMD who have limited or nonexistent upper extremity function while
unsupported retain the ability to generate voluntary movement with their upper
extremities when supported against gravity because of residual strength that is
insufficient to lift the arms against gravity.
The shoulder movements (horizontal abduction, horizontal adduction, and
abduction) had larger AROM difference scores compared to elbow movements
(horizontal elbow flexion and horizontal elbow extension). This can be explained by the
fact that loss of upper extremity function in individuals with DMD typically progresses in
a proximal to distal gradient. Therefore, unsupported shoulder AROM is limited more
significantly prior to loss of unsupported elbow AROM. It would follow that, given the
presence of limited shoulder AROM while unsupported, the elbows will retain a greater
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degree of function and therefore have AROM closer in value to the water-supported
elbow movements.
This aim was a case study and included only one subject. Because of the small
population of individuals with DMD and the limited number of these individuals who
currently participate in aquatic therapy or are willing to participate in a single aquatic
session, the availability of subjects for such a large scale study of this nature is limited. If
a future study were conducted with additional subjects, the researchers could also
measure passive range of motion (PROM) to be used as a measure of “maximum
attainable range”. Doing so could allow researchers to normalize the AROM measures to
the PROM of each subject, allowing for a primary outcome measure of percentage of
maximum AROM instead of measurements in degrees that can be used to more easily
compare between subjects without the consideration of differences in contractures.

3.5 Sub Aim 1.2 Methods
The objective of this sub aim was to quantify the degree of change in upper extremity
AROM of an individual with DMD when the arms are supported against gravity
compared to unsupported movements in a longitudinal study. The degree of voluntary
movement was determined for shoulder and elbow movements while the arms were
unsupported and while the arms were supported against gravity in water in four sessions
over the course of 19 months.
The subject for this sub aim was recruited though the Cerebral Palsy of North
Jersey (CPNJ) Horizon School. The subject was included in the study based on the
following inclusion criteria: DMD diagnosis, late ambulatory stage at study enrollment
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(ability to walk, difficulty climbing stairs and getting up from the floor), regular
participation in aquatic therapy (to ensure safety and comfort in the pool), and no
presence of comorbidities affecting the upper extremities. The subjects was instructed to
perform six movements to the best of his ability: horizontal shoulder abduction and
adduction while upright, shoulder abduction and adduction while supine, and elbow
flexion and extension. Each movement was performed in two conditions: (1) outside a
pool where the arms are unsupported and (2) in a pool where the left and right arms are
supported by the water. The AROM of each movement was recorded using a plastic
universal goniometer with the AROM angle measured in degrees from the start position
to the end of voluntary movement. The AROM difference scores were calculated by
subtracting the unsupported AROM angles from the water-supported AROM angles for
each movement. The primary outcome measure for this study is the AROM angle of
each of the six movements in the water and out of the water. The data collection
procedure was repeated at four sessions over the course of 19 months: 0 months, 5
months, 11 months, and 19 months. The subject’s body, with the exception of the arms,
was supported as needed during the later sessions by an aquatic therapist while in the
water. The portion of the study conducted in the water took place in an accessible, warmwater therapy pool. Figure 3.2 shows an example of the protocol with the subject
performing the supine shoulder abduction movements in and out of the water.
AROM difference scores were computed for each session by subtracting the out
of water AROM angle from the in water AROM angle for each movement.
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Figure 3.2 A subject with DMD performing the supine shoulder abduction movement
with the right arm out of the water (top) and in the water (bottom).

3.6 Sub Aim 1.2 Expected Results
Due to the progressive nature of DMD and the progressive loss of upper extremity
function that continues after ambulation is lost, it is expected that AROM angles will be
similar in the first session, with unsupported AROM movements decreasing at a faster
rate in subsequent sessions compared to water-supported AROM. Accordingly, AROM
difference scores are expected to increase with time for each movement.

33

3.7 Sub Aim 1.2 Results
Figure 3.3 shows the unsupported and water-supported AROM angles for the right arm at
0 months, 5 months, 11 months, and 19 months for one subject with DMD compared to
average joint ranges of motion for individuals with no disability according to [46].
Figure 3.4 shows the same results for the left arm for the same subject. The subject was
late ambulatory at the first and the second session (0 months and 5 months), and
nonambulatory at the final two sessions (11 and 19 months).
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Figure 3.3 AROM results for the right arm from one subject with DMD while out of the water (red) and in the water (blue) over the
course of 19 months (4 sessions) compared to average ranges of joint motion (gray). Circles denote data collection sessions that
occurred while the subject was late ambulatory and asterisks denote data collection sessions that occurred while the subject was
nonambulatory.
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Figure 3.4 AROM results for the left arm from one subject with DMD while out of the water (red) and in the water (blue) over the
course of 19 months (4 sessions) compared to average ranges of joint motion (gray). Circles denote data collection sessions that
occurred while the subject was late ambulatory and asterisks denote data collection sessions that occurred while the subject was
nonambulatory.

Figure 3.5 shows the AROM difference scores for the right arm for each of the 6
movements at 0 months, 5 months, 11 months, and 19 months for one subject with DMD.
Figure 3.6 shows the same result for the left arm for the same subject.

Figure 3.5 AROM difference scores (in water AROM minus out of water AROM) for the
right arm from one subject with DMD over the course of 19 months (4 sessions).
Circles denote data collection sessions that occurred while the subject was late
ambulatory and asterisks denote data collection sessions that occurred while the subject
was nonambulatory.
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Figure 3.6 AROM difference scores (in water AROM minus out of water AROM) for the
left arm from one subject with DMD over the course of 19 months (4 sessions). Circles
denote data collection sessions that occurred while the subject was late ambulatory and
asterisks denote data collection sessions that occurred while the subject was
nonambulatory.

3.8 Sub Aim 1.2 Discussion
The results of this longitudinal case study support the hypothesis that individuals with
DMD have increased AROM when the arms are supported against gravity, a pattern that
is maintained over time in the presence of progressive muscle loss. This indicates that
individuals with DMD who lose the ability to generate unsupported voluntary movements
over time retain enough residual muscle strength to allow for voluntary movements when
supported against gravity.
Overall, AROM difference scores (water-supported AROM minus unsupported
AROM) followed a trend of increasing over time. Furthermore, the AROM difference
scores for shoulder movements (horizontal shoulder abduction, horizontal shoulder
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adduction, supine shoulder abduction, and supine shoulder adduction) were larger when
the subject was nonambulatory compared to when the subject was ambulatory. In other
words, the water-supported AROM values for shoulder movements were larger than
unsupported movements when the subject was nonambulatory.

However, when the

subject was still ambulatory, the water-supported AROM values were larger than
unsupported movements for some cases (right arm supine shoulder adduction and left
arm horizontal shoulder abduction and adduction); smaller than unsupported movements
in some cases (right arm supine shoulder abduction and left arm supine shoulder
abduction); and close to the same as unsupported movements for the remaining cases
(right arm horizontal shoulder abduction and adduction, and left arm supine shoulder
adduction). In other words, the water-supported AROM values for shoulder movements
did not follow a trend, but were roughly the same for a number of shoulder movements
compared to unsupported movements when the subject was still ambulatory. As
expected, these results indicate loss of upper extremity strength over time. Even more,
these results indicate that loss of upper extremity strength that allows an individual with
DMD to generate movements against gravity decreases with time more notably after
ambulation is lost. It follows that support against gravity to augment upper extremity
AROM could be a valuable intervention to allow for increased independence after
ambulation is lost and could become increasingly important as upper extremity strength
continues to decrease over time.
The AROM difference scores for horizontal elbow extension for the left arm and
horizontal elbow flexion for the right arm follow similar patterns to upper extremity
AROM differences scores for shoulder movements. However, the difference scores for
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horizontal elbow flexion for the left arm and horizontal elbow extension for the right arm
do not have a clear trend. This can be explained by the loss of upper extremity strength
in individuals with DMD occurring in a proximal to distal gradient. Individuals with
DMD typically retain distal AROM longer than proximal AROM. Therefore, support
against gravity for the elbows will not provide an increase in AROM that is comparable
in magnitude to that of the shoulders because residual strength remains sufficient to
generate unsupported voluntary elbow movement in the presence of gravity.

This

longitudinal study examined the unsupported and water-supported AROM of a subject
with DMD for less than a year after ambulation was lost. It is expected that following the
same subject for a longer period of time will show trends in AROM difference scores for
the elbow that is similar to that seen for the shoulder in this study as strength is lost over
a longer period of time.
For all data collection sessions (including those when the subject was ambulatory)
the subject exhibited greater ease of movement, smoother movements, and the ability to
generate faster movements in water compared to out of the water.

This was not

necessarily reflected in AROM difference values as, prior to loss of ambulation, the
subject did not have consistently larger in-water AROM compared to unsupported
AROM. This indicates that when in-water and unsupported AROM values were similar,
the movement may still require increased effort from the subject when unsupported
compared to when supported against gravity. Future studies could aim to quantify the
ability of individuals with DMD to generate sustained voluntary movements in and out of
the water and assess fatigue and movement smoothness to further substantiate the
potential benefits of support against gravity for these individuals.
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Similar to sub-aim 1.1, this longitudinal case study included only one subject.
Future studies could also include additional subjects to further substantiate the results and
statistically quantify trends in loss of upper extremity strength over time and the degree
of residual function. However, the small population of individuals with DMD and the
limited number of these individuals willing to participate in a study requiring them to go
into a pool provides a barrier to large-scale studies of this nature.
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CHAPTER 4
AIM 2: ADMITTANCE CONTROL TO INCREASE
UPPER EXTREMITY AROM
4.1 Sub Aim 2.1 Methods
The objective of this sub-aim was to quantify the upper extremity AROM provided by the
HapticMASTER admittance control robot and compare that to the upper extremity
AROM provided by the Armon Edero, a commercially available passive arm support.
The degree of voluntary movement will be determined while the subject’s arms are
supported by the Armon Edero and again while the subject’s arms are supported by the
HapticMASTER robot.
Subjects were recruited for this study though the Parent Project Muscular
Dystrophy DuchenneConnect registry and the Muscular Dystrophy Association. Subjects
were included in the study based on the following criteria: DMD diagnosis, inability to
raise their hands to their mouth or difficulty doing so while holding a weighted object but
some residual hand function (Brooke scale score of 4 or 5), and no presence of
comorbidities affecting the upper extremities. Upper extremity functional status while
using each of the arm supports was quantified with the upper extremity reachable
workspace evaluation developed and validated by Kurillo et al. and Han et al. [9, 47].
The upper extremity reachable workspace evaluation provides a metric for AROM based
on the ability of the subject to perform standardized upper extremity movements. It is
closely associated with upper extremity function and the ability to perform activities of
daily living and has been shown to be sensitive to clinically meaningful changes in upper
extremity function. This method has been shown to be valid, reliable, and sensitive
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enough to detect small changes in upper extremity AROM of individuals with
neuromuscular disorders including DMD [9, 47]. The reachable workspace evaluation
software provides a global metric for upper extremity function, the reachable surface area
score.

Spherical surface data are fit to the hand trajectory data and the envelope is

quantified as a surface area score which is normalized to arm length to allow comparison
of results between subjects [9, 47]. The graphical output and reachable surface area score
from the reachable workspace evaluation software is shown in Figure 4.1 for a subject
with no disability.

Figure 4.1 The reachable workspace evaluation results of one subject with no disability.
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The standardized procedure for the reachable workspace evaluation involves a
subject lifting their arm from a resting position to above the head keeping the elbow
extended. They then repeated the same movement in vertical planes at 0, 45, 90, and 135
degrees followed by horizontal sweeps at the level of the umbilicus and again at the
shoulder. For this aim, all movements were demonstrated to the subject prior to and
during the data collection to ensure uniform speed and execution of the movements.
Subjects were instructed to use only their arms to generate the movement and to not
utilize any compensatory movements. For the purposes of this study, the TrakSTAR
motion capture system was used to track the position of the subject’s left and right
shoulder and the elbow and wrist of the arm being tested, which will be used by the
reachable workspace evaluation software to compute the reachable surface area score.
The reachable workspace evaluation was conducted for the subject’s right and left
arm while unsupported to determine the baseline upper extremity functional status. The
reachable workspace evaluation was also conducted passively, with the researcher
moving the subject’s right and left arms through the reachable workspace evaluation
movements to but not exceeding the joint limits in order to determine the maximum
passive reachable surface area. Additionally, PROM was collected for each subject.
Passive elbow flexion, shoulder forward flexion, shoulder abduction, and shoulder
horizontal flexion were measured from the neutral position with a goniometer according
to the standardized procedures for PROM set forth by the American Academy of
Orthopedic Surgeons [46]. The passive movements measured for this aim were chosen
based on movements that influence reachable workspace in the front of the body. The
passive reachable workspace and PROM measurements were collected in order to
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determine the extent of upper extremity contractures for each subject that may influence
upper extremity function.
Three trials of the reachable workspace evaluation were conducted for the right
and left arms while supported by the Armon Edero passive arm support, as pictured in
Figure 4.2. The support against gravity was adjusted by changing the length of the spring
in order to properly balance the subject’s arm. Three trials of the reachable workspace
evaluation were also conducted for the subject’s right and left arm while supported by the
HapticMASTER robot, also pictured in Figure 4.2. For each arm, the support against
gravity was adjusted by changing the magnitude of an upward constant force in order to
properly balance the subject’s arm.
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Figure 4.2 The Armon Edero passive arm support (top) and the HapticMASTER
admittance control robot (bottom).

Prior to data collection, the workspace of each arm support was aligned to provide
a common frame of reference in order to prevent each subject’s motion from being
restrained by the mechanical limits of either arm support. For both the Armon Edero and
the HapticMASTER, the subjects were given control over the amount of support against
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gravity provided to their arm by instructing the researcher to increase or decrease support
until their arm was “comfortably floating”, felt “weightless”, and provided the greatest
ease of movement. The order in which the subject used the arm supports was randomized
to avoid order effects including fatigue.
At the end of the data collection session, each subject was given a self-assessment
survey (seen in Appendix A) to determine the user’s preferences between the two arm
supports and compare user acceptance of the two technologies. The self-assessment
survey included five questions comparing the Armon Edero and the HapticMASTER.
These questions required subjects to mark their responses on a visual analog scale (VAS),
allowing for statistical comparison of answers [48]. The first two questions asked the
subject to rate the exertion level required to complete the reachable workspace evaluation
movements while supported by the Armon Edero (question 1) and by the
HapticMASTER (question 2). For these questions, the subjects were asked to place a
mark on a 100mm horizontally positioned VAS with the extremities labeled “least
amount of effort” and “most amount of effort”. The VAS was scored by measuring the
distance, in millimeters, from the “least amount of effort” end of the line, with a larger
score representing greater effort required and a lower score representing less effort
required. The next three questions asked the subject to compare the Armon Edero and
HapticMASTER supported movements in the horizontal (question 3) and vertical
(question 4) directions and for overall movements (question 5). For these questions, the
subjects were asked to place a mark on a 100mm horizontally positioned VAS with the
extremities labeled “Armon Edero” and “HapticMASTER”. The VAS was scored by
measuring the distance, in millimeters, from the “Armon Edero” end of the line, with a
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score less than 50 representing easier movement provided by the Armon Edero, a score
larger than 50 representing easier movement provided by the HapticMASTER, and a
score of 50 representing no difference between the two arm supports.
The position data from the reachable workspace evaluation was filtered with a
second order zero-lag, low-pass Butterworth filter with a 6 Hz cutoff frequency. Filtering
was performed in MATLAB. The reachable workspace evaluation software was used to
compute the reachable surface area scores for each trial. The subject’s vertical range of
motion was calculated by subtracting the minimum vertical wrist position from the
maximum vertical wrist position of each reachable workspace evaluation trial. The mean
reachable surface area score and vertical AROM for each subject was determined for
Armon Edero supported movements and for HapticMASTER supported movements for
the left and right arms by taking the average across three trials.
A Shapiro-Wilk test was used to determine if the population of average reachable
surface area difference scores was approximately normal.

If the scores were

approximately normal, a paired–samples t-test was used to determine whether the
HapticMASTER supported movements provide individuals with DMD increased
reachable surface area compared to Armon Edero supported movements.

If the

difference scores violated the assumption of normality, a Wilcoxon signed-ranks test was
used. The same statistical tests were used to compare the subject’s average vertical
AROM for Armon Edero supported movements to HapticMASTER supported
movements. The statistical tests were also repeated to compare the reachable surface area
scores and the vertical AROM between the dominant and non-dominant arms for Armon
Edero and for HapticMASTER supported movements. Similarly, the self-assessment
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survey exertion level scores were compared using the same statistical tests. SPSS was
used for all statistical analyses.
Preliminary reachable surface area scores collected from 6 subjects suggested an
expected effect size of Cohen’s d=1.6 for the comparison of reachable surface area scores
(large effect size). An a priori power analysis, conducted using G*Power 3.1 software,
suggested that a planned sample size of n=6 would be sufficient to obtain a minimum of
80% power (α=0.05, paired-samples t-test) to detect an effect, given this effect size.
Accordingly, a total of 10 subjects participated in this sub aim who met the
inclusion/exclusion criteria in order to achieve a minimum of 80% power. Additionally,
data were collected for one subject with DMD with the ability to fully abduct his arms
while unsupported (Brooke scale score of 1). This subject served as a control for this
study in order to confirm that neither arm support had a larger workspace than the other,
which would bias the data.
Passive reachable surface area, PROM, and unsupported reachable surface area
were collected for each subject for the right and left arms to determine baseline upper
extremity function. The primary outcome measure of this aim is the reachable surface
area scores while supported by the Armon Edero and while supported by the
HapticMASTER robot for both arms. The secondary outcome measure is the vertical
AROM while supported by the Armon Edero and while supported by the
HapticMASTER robot.

The outcome measure to evaluate user preferences are the

subject-reported survey VAS results.
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4.2 Sub Aim 2.1 Expected Results
It is expected that average reachable surface area scores will be greater for
HapticMASTER supported movements compared to Armon Edero supported
movements.

Additionally, the vertical AROM is expected to be larger for

HapticMASTER supported movements compared to Armon Edero supported
movements. The self-assessment survey exertion level scores are expected to be smaller
for HapticMASTER supported movements and all subjects are expected to rate the
HapticMASTER as providing greater ease of movement. These results are expected
because the HapticMASTER robot operates under admittance control which provides
more precise gravity compensation and minimized friction and inertia compared to
passive arm supports.
It is expected that the mean reachable surface area scores will be greater for the
dominant arm compared to the non-dominant arm for Armon Edero and for
HapticMASTER supported movements. Additionally, the vertical AROM is expected to
be larger for the dominant arm compared to the non-dominant arm for Armon Edero and
for HapticMASTER supported movements.

These results are expected because the

dominant arm is used most often while performing activities of daily living and, unlike
the non-dominant arm, has the potential to be less susceptible to disuse atrophy.

4.3 Sub Aim 2.1 Results
Ten subjects and one control subject with DMD who met the inclusion and exclusion
criteria for this aim were enrolled in the study. Table 4.1 shows the age of each subject,
handedness, and baseline scores of passive reachable surface area and unsupported
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reachable surface area for the left and right arms. Table 4.2 shows the PROM results for
each subject for the left and right arms.

Table 4.1 Subjects Enrolled in Aim 2.1
Subject
1a
2a
3a
4a
5a
6a
7a
8a
9a
10a
Control

Age
26
21
14
26
27
14
14
17
11
15
15

Hand Dominance

Passive RSA
Unsupported RSA
Right
Left
Right
Left
Right
0.713
0.321
0.100
0.032
Right
0.403
0.184
0.007
0.000
Right
0.488
0.296
0.000
0.000
Right
0.524
0.227
0.001
0.000
Right
0.435
0.709
0.000
0.000
Right
0.707
0.615
0.165
0.020
Right
0.696
0.549
0.025
0.011
Right
0.622
0.446
0.106
0.037
Right
0.628
0.598
0.033
0.013
Right
0.46
0.482
0.000
0.000
Right
0.437
0.470
0.420
0.275

Table 4.2 Passive Range of Motion (PROM) for Subjects in Aim 2.1
Elbow Flexion Shoulder Forward
Shoulder
Shoulder Horizontal
(deg)
Flexion (deg)
Abduction (deg)
Flexion (deg)
Right Left Right
Left
Right
Left Right
Left
1a
113 106
140
145
107
135
94
115
2a
115 114
122
92
116
114
95
93
3a
89
92
126
99
120
98
96
92
4a
91
92
98
94
105
89
96
90
5a
116 108
105
92
120
110
95
105
6a
94 110
123
130
123
114
120
94
7a
110 100
110
150
95
112
116
137
8a
135 102
120
93
94
85
95
111
9a
128 108
149
138
124
130
118
107
10a
142
151
150
153
110
114
110
113
Control
133 134
144
155
143
140
102
100
Subject
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Figure 4.3 shows the reachable workspace evaluation software graphical output
for a single subject while the dominant arm is moved passively by the researcher,
unsupported, supported by the Armon Edero passive arm support, and supported by the
HapticMASTER robot. For this subject, the reachable surface area when the arm is
supported by the HapticMASTER robot is larger than when the arm is supported by the
Armon Edero and when the arm is unsupported. Additionally, the unsupported reachable
surface area was larger than Armon Edero supported movements. The HapticMASTER
allowed for a larger reachable surface are score compared to the Armon Edero. As seen
in the figure, the Armon Edero and the HapticMASTER allowed for bilateral reachable
surface area above the lap compared to unsupported reachable surface area limited
laterally to the right and mostly below the level of the stomach. The figure also shows
increased vertical and horizontal distribution of reachable surface area allowed by the
HapticMASTER robot compared to the Armon Edero.
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Figure 4.3 The reachable workspace evaluation results from one subject for a single trial
while the dominant arm was moved passively by the researcher (top left), unsupported
(top right), supported by the Armon Edero passive arm support (bottom left), and
supported by the HapticMASTER robot (bottom right).
Figure 4.4 shows the mean reachable surface area scores of Armon Edero and
HapticMASTER supported movements for the dominant and non-dominant arms for all
10 subjects. A Shapiro-Wilk test revealed that the reachable surface area difference
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scores for the dominant arm have a significant deviation from normality (p=0.004). The
HapticMASTER robot significantly increased reachable surface area scores for the
dominant arm compared to the Armon Edero passive arm support (Wilcoxon T=5.00,
p=0.022, r2=0.26). An r2=0.26 denotes a large effect of the HapticMASTER on dominant
reachable surface area compared to the Armon Edero. A Shapiro-Wilk test revealed that
the reachable surface area difference scores for the non-dominant arm have no significant
deviation from normality (p=0.262). The HapticMASTER significantly increase
reachable surface area scores for the non-dominant arm compared to the Armon Edero
passive arm support (paired-samples t-test, t(9)=4.66, p=0.001, r 2=0.71). An r2=0.71
denotes a large effect of the HapticMASTER on non-dominant reachable surface area
compared to the Armon Edero. A Shapiro-Wilk test revealed that the reachable surface
area difference scores for Armon Edero supported movements for the dominant arm
compared to the non-dominant arm have a significant deviation from normality
(p=0.009). The dominant arm had significantly increased reachable surface area scores
compared to the non-dominant arm while supported by the Armon Edero passive arm
support (Wilcoxon T=0.00, p=0.005, r2=0.39). An r2=0.39 denotes a large effect of hand
dominance on reachable surface area for Armon Edero supported movements.

A

Shapiro-Wilk test revealed that the reachable surface area difference scores for
HapticMASTER supported movements for the dominant arm compared to the nondominant arm have a significant deviation from normality (p=0.002). The dominant arm
had significantly increased reachable surface area scores compared to the non-dominant
arm for HapticMASTER supported movements (Wilcoxon T=1.00, p=0.002, r 2=0.37).
An r2=0.37 denotes a large effect of hand dominance on reachable surface area for
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HapticMASTER supported movements.

The control subject had a mean reachable

surface area score of 0.232 for Armon Edero supported movements and 0.189 for
HapticMASTER supported movements for the dominant arm and 0.167 for Armon Edero
supported movements and 0.121 for HapticMASTER supported movements for the nondominant arm.

*
*

*

*

Figure 4.4 Mean reachable surface area scores for Armon Edero and HapticMASTER
supported movements for all 10 subjects for the dominant (blue) and non-dominant
(green) arms. Error bars show SEM. Asterisks denote statistical significance between
groups (p<0.05).
Figure 4.5 shows the mean vertical AROM for Armon Edero and
HapticMASTER supported movements for the dominant and non-dominant arms for all
10 subjects. A Shapiro-Wilk test revealed that the vertical AROM for the dominant arm
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difference scores have no significant deviation from normality (p=0.697). The
HapticMASTER significantly increase vertical AROM for the dominant arm compared to
the Armon Edero passive arm support (paired-samples t-test, t(9)=2.37, p=0.042,
r2=0.39). An r2=0.39 denotes a large effect of the HapticMASTER on dominant arm
vertical AROM compared to the Armon Edero. A Shapiro-Wilk test revealed that the
vertical AROM difference scores for the non-dominant arm have no significant deviation
from normality (p=0.887). The HapticMASTER significantly increased vertical AROM
for the non-dominant arm compared to the Armon Edero passive arm support (pairedsamples t-test, t(9)=8.899, p<0.001, r2=0.90). An effect size of r2=0.90 denotes a large
effect of the HapticMASTER on non-dominant arm vertical AROM compared to the
Armon Edero. A Shapiro-Wilk test revealed that the vertical AROM difference scores
for Armon Edero supported movements for the dominant arm compared to the nondominant arm had no significant deviation from normality (p=0.437). There was no
significant change between the dominant arm and the non-dominant arm for Armon
Edero supported movements (paired-samples t-test, t(9)=1.50, p=0.169). A Shapiro-Wilk
test revealed that the vertical AROM difference scores for HapticMASTER supported
movements for the dominant arm compared to the non-dominant arm had a significant
deviation from normality (p=0.041). There was no significant difference between the
dominant arm and the non-dominant arm for HapticMASTER supported movements
(Wilcoxon T=19.00, p=0.386). The control subject also had a vertical AROM of 437mm
for Armon Edero supported movements and 423 for HapticMASTER supported
movements for the dominant arm and 453mm for Armon Edero supported movements
and 381 for HapticMASTER supported movements for the non-dominant arm.
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*
*

Figure 4.5 Mean vertical AROM for Armon Edero and HapticMASTER supported
movements for all 10 subjects for the dominant (blue) and non-dominant (green) arms.
Error bars show SEM. Asterisks denote statistical significance between groups (p<0.05).
Figure 4.6 shows the mean subject-reported VAS exertion scores values for
Armon Edero and HapticMASTER supported movements. A Shapiro-Wilk test revealed
that the self-reported exertion level scores have no significant deviation from normality
(p=0.852). The HapticMASTER significantly decreased subject-reported exertion level
scores compared to the Armon Edero passive arm support (paired-samples t-test, t(9)=4.45, p=0.002, r2=0.69). An r2=0.69 denotes a large effect of the HapticMASTER on
exertion level compared to the Armon Edero. The control subject had a self-reported
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exertion level score of 74 for Armon Edero supported movements and 7 for
HapticMASTER supported movements.

*

Figure 4.6 Mean subject-reported exertion level scores for Armon Edero and
HapticMASTER movements. Error bars show SEM. Asterisk denotes statistical
significance between groups (p<0.05).
Figure 4.7 shows the mean subject-reported VAS scores comparing the Armon
Edero and HapticMASTER supported horizontal, vertical, and overall movements. The
mean VAS response for horizontal movements was 86mm (SD 4mm), with all subjects
reporting that the HapticMASTER allowed for the easiest movements in the horizontal
direction compared to the Armon Edero.
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The mean VAS response for vertical

movements was 67mm (SD 10mm), denoting that, on average, subjects reported that the
HapticMASTER allowed for the easiest movements in the vertical direction compared to
the Armon Edero. The mean VAS response for overall movements was 84mm (SD
5mm), denoting that all subjects reported that the HapticMASTER allowed for the easiest
movements overall, with the exception of one outlier who reported a score of 49mm. The
control subject reported a VAS score of 93 for horizontal movements, 94 for vertical
movements, and 90 for overall movements.
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Figure 4.7 Mean subject-reported VAS scores comparing the Armon Edero and
HapticMASTER supported horizontal movements, vertical movements, and overall
movements. Scores greater than 50 denote a preference for the HapticMASTER robot
and scores less than 50 denote a preference for the Armon Edero. Circles denote outliers
greater than 1.5 interquartile range from Q1 or Q3.
4.4 Sub Aim 2.1 Discussion
This study explored the effect of admittance control on upper extremity movements in
individuals with DMD compared to a commercially available passive arm support. The
results support the hypothesis that admittance control increases the AROM of individuals
with DMD to a greater degree than a commercially available passive arm support. The
reachable surface area scores demonstrate an overall increase in AROM for the dominant
and non-dominant arms for HapticMASTER supported movements compared to Armon
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Edero supported movements. These results imply that that admittance control allows
increased ease of movement compared to passive arm supports, explained by the
minimization of friction and inertia and improved gravity compensation provided by
admittance control. The vertical AROM results demonstrate an increase in voluntary
vertical movements opposed by gravity, explained by the constants upward force
provided by the HapticMASTER robot that is used to support the arm against gravity.
This gravity compensation method is more precise than the spring of the Armon Edero
that brings the arm to a set-point but requires additional force from the user to generate
movements above or below this set-point. The subject-reported exertion level results
imply that users found the admittance control arm support to require less strength to
generate movements compared to the passive arm support, explained by the intuitive
control and ease of movement provided by admittance control. Overall, subjects reported
a preference for the admittance control robot compared to the passive arm support for
assistance with voluntary movement, as reflected in mean subject-reported VAS scores of
greater than 50.
The reachable surface area scores show an increase in AROM for the dominant
arm compared to the non-dominant arm for both Armon Edero and HapticMASTER
supported movements. The dominant arm is used more frequently in daily living tasks
and is therefore less susceptible to disuse atrophy. It would follow that the dominant arm
has a greater degree of residual strength resulting in larger reachable surface area scores
when supported against gravity.
The effect size (r2) for the statistically significant improvement in reachable
surface area scores and vertical AROM for HapticMASTER supported movements is
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larger for the non-dominant arm compared to the dominant arm. Given that unsupported
reachable surface area scores were smaller for the non-dominant arm, indicating less
residual strength than the dominant arm, the effect size results indicate that the benefits of
admittance control becomes more substantial compared to a passive arm support as an
individual loses muscle strength. This result can be explained by the fact that passive
arm supports are useful only for those in the earlier stages of functional loss as residual
strength is sufficient to provide a functional increase in AROM.
The HapticMASTER provided subjects with three translational DOFs in the x, y,
and z directions and one passive rotational DOF in the yaw direction, with roll and pitch
movements restricted. The Armon Edero restricted roll movements only, allowing
passive x, y, z, pitch and yaw. Even more, approximate maximum workspace of the
Armon Edero (0.087m2) is larger than the maximum workspace of the HapticMASTER
(0.067m2). For these reasons, it is expected that any bias in results would occur toward
the Armon Edero and not the HapticMASTER. This is further supported by the results
from the control subject who exhibited larger reachable surface area scores and vertical
AROM while using the Armon Edero compared to the HapticMASTER. It is expected
that an admittance control robot equal in maximum workspace and DOFs to a passive
arm support will result in a larger increase in reachable surface area and vertical AROM
than reported in this study. Additionally, the control subject reported smaller exertion
level scores and larger VAS scores for the HapticMASTER compared to the Armon
Edero despite having greater AROM with the passive arm support. These results indicate
that an individual who has sufficient muscle strength to benefit from a passive arm
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support may still find an admittance control arm support easier to use and preferable to a
passive arm support.
The HapticMASTER robot was set to an inertia value of 6kg in order to keep the
system stable and allow for safe user-robot interaction. Therefore, the user was opposed
only by the inertia of a 6kg frictionless point mass. The Armon Edero weighs
approximately 1.8kg and the human arm has a mass of about 5% of the total body mass.
Therefore, the inertia opposing the movements of an 80kg person using the Armon Edero
would be approximately 6kg, about equal to that of the HapticMATSER robot. Because
the inertia of the Armon Edero and the HapticMASTER robot is approximately the same,
it is expected that the improvements in reachable surface area scores, vertical AROM,
exertion level scores, and VAS scores are due primarily to the improved gravity
compensation provided by the HapticMASTER robot compared to the Armon Edero. It
is expected that an admittance control arm support with the virtual mass inertia value set
lower than 6kg will result in a larger increase in reachable surface area and vertical
AROM and a larger decrease in exertion level than reported in this study. This introduces
the potential of admittance control to be beneficial to individuals with DMD in the later
stages of functional loss.

4.5 Sub Aim 2.2 Methods
The objective of this sub aim was to track the changes in upper extremity AROM
provided by the HapticMASTER in a longitudinal study over the course of about one
year and compare that to the changes in upper extremity AROM provided by the Armon
Edero over the same period of time. Subjects were recruited for this study though the
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Parent Project Muscular Dystrophy DuchenneConnect registry and the Muscular
Dystrophy Association.

Subjects were included in the study using the same

inclusion/exclusion criteria as sub aim 2.1.
The data collection protocol in sub-aim 2.1 was repeated for each subject at 3
sessions over the course of about 1 year to determine if the increase in AROM provided
by the HapticMASTER would be sustained over that period of time. Average reachable
surface area and average vertical AROM was calculated across 3 trials for each session
for the right and left arms for Armon Edero and HapticMASTER supported movements.
Unsupported and passive reachable workspace and subject-reported exertion level scores
were also collected at each session using the same protocol as sub aim 2.1 to track
changes in baseline upper extremity function, contractures, and user preferences.
In order to track changes in upper extremity strength, each subject’s force output
capabilities was quantified by conducting maximum voluntary isometric contraction
(MVIC) for eight shoulder- and elbow-resisted movements. MCIV, among the most
common measurement techniques that has been used extensively with individuals with
neuromuscular conditions, is a safe and simple method used to quantify muscle strength
[49]. MVIC was conducted while each subject’s shoulder is abducted in neutral flexion,
abduction, and rotation with the elbow flexed at 90 degrees and the forearm position in
neutral pronation/supination, a protocol adapted from Burgar, et al. [50]. The subject’s
arm was strapped into a stationary cuff attached to an ATI Industrial Automation force
sensor. The peak normal force was recorded for eight movements: elbow flexion, elbow
extension, external rotation, internal rotation, shoulder abduction, shoulder adduction,
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shoulder flexion, and shoulder extension. Peak force values were collected and averaged
across three trials for the right and left arms.
The reachable workspace evaluation trajectory data was filtered and analyzed
using the same protocol from sub aim 2.1. An examination of studentized residuals for
values greater than +/-3 was used to determine if there were any outliers for reachable
surface area scores, vertical AROM, and subject-reported exertion level scores.

A

Shapiro-Wilk test was used to assess the normality of the studentized residuals.
Mauchly’s test of sphericity was used to test the assumption of sphericity. A two-way
repeated measures ANOVA was used to compare the reachable surface area scores, the
vertical AROM, and the self-reported exertion level scores for the Armon Edero and
HapticMASTER movements at each of the three sessions for the dominant and nondominant arms.
A Shapiro-Wilk test was used to assess if the population for time, reachable
surface area scores, vertical AROM, and subject-reported exertion level scores are
normally distributed. If the population for these variables is approximately normal and
the assumption of homoscedasticity is met then a Pearson’s r was used to assess the
relationship between time and reachable surface area scores, vertical AROM, and subject
reported exertion level scores. If either of the assumptions are violated, a Spearman’s
rank-order correlation was run to assess the relationship. The same statistical tests were
used to assess the relationship between the Armon Edero and HapticMASTER supported
reachable surface area scores and vertical AROM and shoulder abduction, adduction,
flexion, and extension MVIC.
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Passive reachable surface area, MVIC, and unsupported reachable surface area
were outcome measures used to track the upper extremity functional status of the subjects
at each session. The primary outcome measure of this sub aim is the reachable surface
area scores while supported by the Armon Edero and while supported by the
HapticMASTER robot at each of the three sessions. The secondary outcome measure is
the vertical AROM while supported by the Armon Edero and while supported by the
HapticMASTER robot at each of the three sessions. The outcome measure to evaluate
user preferences is the subject-reported exertion level scores.

4.6 Sub Aim 2.2 Expected Results
Due to the progressive nature of DMD, it is expected that unsupported reachable surface
area, passive reachable surface area, and MVIC will decrease with each session. It is
expected that the reachable surface area scores will decrease over time for both the
HapticMASTER and Armon Edero supported movements. However, because of the
benefits of admittance control, it is expected that the reachable surface area scores for the
HapticMASTER supported movements will remain larger and decrease at a slower rate
compared to the Armon Edero supported movements at each session. Similarly, vertical
range of motion is expected to remain larger and decrease at a slower rate for
HapticMASTER supported movements compared to Armon Edero supported
movements. The self-reported exertion level scores are expected to remain smaller for
the HapticMASTER while also increasing at a slower rate compared to the Armon Edero.
It is expected that time is positively correlated with Armon Edero and
HapticMASTER supported reachable surface area scores and vertical AROM and
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negatively correlated with subject-reported exertion level scores. It is expected that
shoulder abduction, adduction, flexion, and extension MVIC are positively correlated
with Armon Edero and HapticMASTER supported reachable surface area scores and
vertical AROM.

4.7 Sub Aim 2.2 Results
Five subjects and one control subject with DMD who met the inclusion and exclusion
criteria for this aim were enrolled in the study. Table 4.3 shows the age of each subject,
handedness, baseline scores of passive reachable surface area and unsupported reachable
surface area for the left and right arms at the first session, and the month each session was
conducted for each subject.

Session 1 was conducted at month 0, session 2 was

conducted between months 3 and 6, and session 3 was conducted between months 9-12.

Table 4.3 Subjects Enrolled in Aim 2.2
Subject Age Hand Dominance Passive RSA Unsupported RSA Session (months)
Right Left Right
Left
1
2
3
1b
26
Right 0.713 0.321
0.100
0.032
0
4
11
2b
21
Right 0.403 0.184
0.007
0.000
0
4
12
3b
26
Right 0.524 0.227
0.001
0.000
0
3
9
4b
27
Right 0.435 0.709
0.000
0.000
0
4
11
5b
11
Right 0.628 0.598
0.033
0.013
0
6
11
Control 15
Right 0.437 0.470
0.420
0.275
0
5
10
Figure 4.8 shows the passive reachable surface area scores for the dominant arm
for all 6 subjects at each of the 3 sessions. Subjects 1, 2, 3, and 5 had a smaller passive
reachable surface area score for the dominant arm at their third session compared to their
first session, indicating an increase in the development of contractures over the course of
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the study. Subject 4 and the control subject had larger passive reachable surface area
scores for the dominant arm at their third session compared to their first indicating a
decrease in contractures over the course of the study.

Figure 4.8 Passive reachable surface area scores for the dominant arm for 5 subjects and
1 control subject with DMD over 3 sessions.
Figure 4.9 shows the passive reachable surface area scores for the non-dominant
arm at the same 3 sessions. Subjects 3, 4, 5, and 6 had smaller passive reachable surface
area scores for the non-dominant arm at their third session compared to their first session,
indicating an increase in contractures over the course of the study. Subjects 1 and 2 had
larger passive reachable surface area scores for the non-dominant arm at their third
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session compared to their first session, indicating a decrease in contractures over the
course of the study.

Figure 4.9 Passive reachable surface area scores for the non-dominant arm for 6 subjects
with DMD over 3 sessions.
Figure 4.10 shows the unsupported reachable surface area scores for the dominant
arm for all 5 subjects. Subjects 1, 2, and 5 had a smaller unsupported reachable surface
area score for the dominant arm at their third session compared to their first session,
indicating a decrease in upper extremity function over the course of the study. Subject 4
had an unsupported reachable surface area score for the dominant arm of 0.000 at each
session and therefore had no change between sessions. Subjects 3 had larger unsupported
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reachable surface area scores for the dominant arm at the third session compared to the
first session, indicating no decrease in upper extremity function over the course of the
study.

The control subject has unsupported reachable surface area scores for the

dominant arm of 0.420 at session 1, 0.419 at session 2, and 0.462 at session 3. The
control subject had larger unsupported reachable surface area scores at the third session
compared to the first session.

Figure 4.10 Unsupported reachable surface area scores for the dominant arm for 5
subjects with DMD over 3 sessions.
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Figure 4.11 shows the unsupported reachable surface area scores for the nondominant arm for all 5 subjects at the same 3 sessions. Subjects 1 and 5 had smaller
unsupported reachable surface area scores for the non-dominant arm at the third session
compared to the first session, indicating a decrease in upper extremity function over the
course of the study. Subjects 2, 3, and 4 had larger unsupported reachable surface area
scores for the non-dominant arm at the third session compared to the first session,
indicating no decrease in upper extremity function over the course of the study. The
control subject had unsupported reachable surface area scores for the non-dominant arm
of 0.275 at session 1 and 0.242 at session 2. There was no data available for the
unsupported reachable surface area for the non-dominant arm for the control subject at
the third session. The control subject had a smaller unsupported reachable surface area
score at the second session compared to the first session.
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Figure 4.11 Unsupported reachable surface area scores for the non-dominant arm for 5
subjects with DMD over 3 sessions.
Figure 4.12 shows the reachable surface area scores for the dominant arm for Armon
Edero and for HapticMASTER supported movements for all 5 subjects and 1 control
subject over 3 sessions. Subjects 1, 2, and 4 had larger reachable surface area scores for
HapticMASTER supported movements compared to Armon Edero supported movements
for the dominant arm at all sessions. Subjects 3 and 5 had larger reachable surface area
scores for HapticMASTER supported movements compared to Armon Edero supported
movements for the dominant arm at all sessions except session 2 (subject 3) and session 1
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(subject 5). The control subject had larger reachable surface area scores for Armon
Edero supported movements for the dominant arm at session 1 and 2 and had larger
reachable surface area scores for HapticMASTER supported movements at session 3.

Figure 4.12 Reachable surface area scores for the dominant arm for Armon Edero (blue)
and HapticMASTER (red) supported movements for 5 subjects and 1 control subject
with DMD over 3 sessions.
Figure 4.13 shows the reachable surface area scores for the non-dominant arm for
Armon Edero and for HapticMASTER supported movements for all 5 subjects and 1
control subject over 3 sessions. Subjects 2, 4, and 5 had larger reachable surface area
scores for HapticMASTER supported movements compared to Armon Edero supported
movements for the non-dominant arm at all session.

Subjects 1 and 3 had larger

reachable surface area scores for HapticMASTER supported movements compared to
Armon Edero supported movements for the non-dominant arm at all sessions except for
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session 3. The control subject had larger reachable surface area scores for Armon Edero
supported movements for the non-dominant arm at sessions 1 and 3 and had larger
reachable surface area scores for HapticMASTER supported movements at session 2.

Figure 4.13 Reachable surface area scores for the non-dominant arm for Armon Edero
(blue) and HapticMASTER (red) supported movements for 5 subjects and 1 control
subject with DMD over 3 sessions.
Figure 4.14 shows the vertical AROM for the dominant arm for Armon Edero and
for HapticMASTER supported movmeents for all 5 subjects and 1 control subject over 3
sessions. Subjects 1 and 4 had larger vertical AROM for HapticMASTER supported
movements compared to Armon Edero supported movements for the dominant arm at all
3 sessions. Subjects 2 and 3 had larger vertical AROM for HapicMASTER supported
movements compared to Armon Edero supported movements for the dominant arm at all
sessions except for session 2 (subject 2) and session 2 and 3 (subject 3). Subject 5 and
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the control subject had larger vertical AROM for Armon Edero supported movements
compared to HapticMASTER supported movements for the dominant arm at all 3
sessions.

Figure 4.14 Vertical AROM for the dominant arm for Armon Edero (blue) and
HapticMASTER (red) supported movements for 5 subjects and 1 control subject with
DMD over 3 sessions.
Figure 4.15 shows the vertical AROM for the non-dominant arm for Armon
Edero and for HapticMASTER supported movements for all 5 subjects and 1 control
subject over 3 sessions.

Subjects 1, 2, 4, and 5 had larger vertical AROM for

HapticMASTER supported movements compared to Armon Edero supported movements
for the non-dominant arm at all 3 sessions.

Subject 3 had larger HapticMASTER

supported movements compared to Armon Edero supported movements for the nondominant arm at all sessions except for session 3. The control subject had larger vertical
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AROM for Armon Edero supported movements for the non-dominant arm at sessions 1
and 3 and larger HapticMASTER supported movements at session 2.

Figure 4.15 Vertical AROM for the non-dominant arm for Armon Edero (blue) and
HapticMASTER (red) supported movements for 5 subjects and 1 control subject with
DMD over 3 sessions.
Figure 4.16 shows the mean reachable surface area for Armon Edero and
HapticMASTER supported movements for the dominant arm for all 5 subjects and 1
control subject across 3 sessions. The mean reachable surface area scores were 0.052
(SD 0.043) for Armon Edero supported movements and 0.070 (SD 0.054) for
HapticMASTER supported movements for session 1, 0.058 (SD 0.047) for Armon Edero
supported movements and 0.091 (SD 0.079) for HapticMASTER supported movements
for session 2, and 0.051 (SD 0.036) for Armon Edero supported movements and 0.063
(SD 0.041) for HapticMASTER supported movements for session 3. The control subject
had reachable surface area scores for Armon Edero supported movements of 0.232 at
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session 1, 0.268 at session 2, and 0.214 at session 3. The control subject had reachable
surface area scores for HapticMASTER supported movements of 0.189 at session 1,
0.184 at session 2, and 0.241 at session 3. There were no outliers, as assessed by
examination of studentized residuals for values greater than +/-3. Reachable surface area
scores for the dominant arm were normally distributed (p>0.05), as assessed by ShapiroWilk’s test of normality on the studentized residuals.

Mauchly’s test of sphericity

indicated that the assumption of sphericity was met for the two-way interaction
(χ2(2)=0.683, p=0.711). Mauchly’s test of sphericity also indicated that the assumption
of sphericity was met for session number (χ2(2)=0.258, p=0.879).

There was no

statistically significant two-way interaction between arm support type and session
number (F(2,8)=0.812, p=0.478).

The main effect of arm support type showed no

statistically significant difference in reachable surface area scores (F(1,4)=4.411,
p=0.104).

The main effect of session number showed no statistically significant

difference in reachable surface area (F(2,8)=1.353, p=0.312).
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Figure 4.16 Mean reachable surface area for Armon Edero (blue) and HapticMASTER
(green) supported movements for the dominant arm (n=5) at 3 sessions. Error bars show
SEM.
Figure 4.17 shows the mean reachable surface area for Armon Edero and
HapticMASTER supported movements for the non-dominant arm for all 5 subjects across
3 sessions. The mean reachable surface area scores were 0.020 (SD 0.014) for Armon
Edero supported movements and 0.045 (SD 0.028) for HapticMASTER supported
movements for session 1, 0.035 (SD 0.031) for Armon Edero supported movements and
0.075 (SD 0.052) for HapticMASTER supported movements for session 2, and 0.039 (SD
0.030) for Armon Edero supported movements and 0.046 (SD 0.038) for
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HapticMASTER supported movements for session 3. The control subject had reachable
surface area scores for Armon Edero supported movements of 0.167 at session 1, 0.108 at
session 2, and 0.186 at session 3. The control subject had reachable surface area scores
for HapticMASTER supported movements of 0.121 at session 1, 0.168 at session 2, 0.121
at session 3. There were no outliers, as assessed by examination of studentized residuals
for values greater than +/- 3. Reachable surface area scores for the non-dominant arm
were normally distributed (p>0.05), as assessed by Shapiro-Wilk’s test of normality on
the studentized residuals. Mauchly’s test of sphericity had been violated for the two-way
interaction, (χ2(2)=6.176, p=0.046).

Mauchly’s test of sphericity indicated that the

assumption of sphericity was met for session number (χ 2(2)=0.040, p=0.980). There was
no statistically significant two-way interaction between arm support type and session
number (F(1.068,4.273)=7.110 p=0.640). The main effect of arm support type showed
no statistically significant difference in reachable surface area scores (F(1,4)=12.992,
p=0.023).

The main effect of session number showed no statistically significant

difference in reachable surface area (F(2,8)=3.005, p=0.106).
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Figure 4.17 Mean reachable surface area for Armon Edero (blue) and HapticMASTER
(green) supported movements for the non-dominant arm (n=5) 3 sessions. Error bars
show SEM.
Figure 4.18 shows the mean vertical AROM for Armon Edero and
HapticMASTER supported movements for the dominant arm for all 5 subjects across 3
sessions.

The mean vertical AROM was 180mm (SD 124mm) for Armon Edero

supported movements and 231mm (SD 103mm) for HapticMASTER supported
movements for session 1, 220mm (SD 125mm) for Armon Edero supported movements
and 227mm (SD 104mm) for HapticMASTER supported movements for session 2, and
223mm (SD 121mm) for Armon Edero and 225mm (SD 96mm) for HapticMASTER
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supported movements for session 3. The control subject had vertical AROM for Armon
Edero supported movements of 437mm at session 1, 448mm at session 2, and 402mm at
session 3.

The control subject had vertical AROM for HapticMASTER supported

movements of 423mm at session 1, 422mm at session 2, 392mm at session 3. There were
no outliers, as assessed by examination of studentized residuals for values greater tha +/3. Vertical AROM for the dominant arm were normally distributed (p>0.05), as assessed
by Shapiro-Wilk’s test of normality on the studentized residuals. Mauchly’s test of
sphericity indicated that the assumption of sphericity was met for the two-way
interaction, (χ2(2)=3.867, p=0.145).

Mauchly’s test of sphericity indicated that the

assumption of sphericity was met for session number (χ 2(2)=3.342, p=0.188). There was
no statistically significant two-way interaction between arm support type and session
number (F(2,8)=1.774, p=0.230).

The main effect of arm support type showed no

statistically significant difference in vertical AROM, (F(1,4)=1.234, p=0.329). The main
effect of session number showed no statistically significant difference in vertical AROM
(F(2,8)=0.925, p=0.435).
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Figure 4.18 Mean vertical AROM for Armon Edero (blue) and HapticMASTER (green)
supported movements for the dominant arm (n=5) at 3 sessions. Error bars show SEM.
Figure 4.19 shows the mean vertical AROM for Armon Edero and
HapticMASTER supported movements for the non-dominant arm for all 5 subjects across
3 sessions.

The mean vertical AROM was 169mm (SD 99mm) for Armon Edero

supported movements and 230mm (SD 86mm) for HapticMASTER supported
movements for session 1, 173mm (SD 116mm) for Armon Edero supported movements
and 252mm (SD 109mm) for HapticMASTER supported movements for session 2, and
188mm (106mm) for Armon Edero supported movements and 213mm (SD 95mm) for
HapticMASTER supported movements for session 3. The control subject had vertical
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AROM for Armon Edero supported movements of 453mm at session 1, 369mm at
session 2, and 424mm at session 3.

The control subject had vertical AROM for

HapticMASTER supported movements of 381mm, 418mm, 362mm for sessions 1, 2, and
3. There were no outliers, as assessed by examination of studentized residuals for values
greater tha +/- 3. Vertical AROM for the non-dominant arm were normally distributed
(p>0.05), as assessed by Shapiro-Wilk’s test of normality on the studentized residuals.
Mauchly’s test of sphericity had been violated for the two-way interaction, (χ2(2)=6.461,
p=0.040). Mauchly’s test of sphericity indicated that the assumption of sphericity was
met for session number (χ2(2)=1.117, p=0.572). There was no statistically significant
two-way

interaction

between

(F(1.062,4.246)=1.995, p=0.229).

arm

support

type

and

session

number

The main effect of arm support type showed a

statistically significant difference in vertical AROM, (F(1,4)=36.233, p=0.004). The
mean difference between vertical AROM is 55mm (95% CI, -81mm, -29mm). The main
effect of session number showed no statistically significant difference in vertical AROM
(F(2,8)=0.0.546, p=0.600).
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Figure 4.19 Mean vertical AROM for Armon Edero (blue) and HapticMASTER (green)
supported movements for the non-dominant arm (n=5) at 3 sessions. Error bars show
SEM.
Figure 4.20 shows the mean subject-reported exertion level scores for the Armon
Edero and HapticMASTER supported movements for all 3 sessions. The mean subjectreported exertion level score was 60mm (SD 21mm) for Armon Edero supported
movements and 28mm (SD 22mm) for HapticMASTER supported movements for
session 1, 85mm (SD 15mm) for Armon Edero supported movements and 31mm (SD
22mm) for HapticMASTER supported movements for session 2, and 73mm (SD 13mm)
for Armon Edero and 12mm (SD 10mm) for HapticMASTER supported movmenets for
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session 3. The control subject reported exertion level scores for the Armon Edero of
74mm at session 1, 60mm at session 2, and 83mm at session 3. The control subject
reported exertion level scores for HapticMASTER supported movements of 7mm at
session 1, 31mm at session 2, and 9mm at session 3. There were no outliers, as assessed
by examination of studentized residuals for values greater tha +/- 3. Subject-reported
exertion level scores were normally distributed (p>0.05), as assessed by Shapiro-Wilk’s
test of normality on the studentized residuals. Mauchly’s test of sphericity indicated the
assumption of sphericity was met for the two-way interaction, (χ2(2)=0.717, p=0.407).
Mauchly’s test of sphericity indicated that the assumption of sphericity was met for
session number (χ2(2)=1.796, p=0.699). There was a statistically significant two-way
interaction between arm support type and session number, (F(2,8)=15.014, p=0.002).
The mean difference in exertion level scores was 32mm (95% CI, 15mm to 49mm) for
Armon Edero supported movements compared to HapticMASTER supported movements
at session 1. This was a statistically significant difference (F(1,4)=25.924, p=0.007).
The mean difference in exertion level scores was 54mm (95% CI, 38mm to 70mm) for
Armon Edero supported movements compared to HapticMASTER supported movements
at session 2. This was a statistically significant difference (F(1,4)=89.726, p=0.001).
The mean difference in exertion level scores was 61mm (95% CI, 42mm to 80mm) for
Armon Edero supported movements compared to HapticMASTER supported movements
at session 3. This was a statistically significant difference (F(1,4)=81.176, p=0.001).
There was no statistically significant effect of session number on exertion level for
Armon Edero supported movements (F(2,8)=4.215, p=0.056). There was no statistically
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significant effect of session number on exertion level for HapticMASTER supported
movements (F(2,8)=3.150, p=0.098).

Figure 4.20 Mean subject-reported exertion level scores for Armon Edero (blue) and
HapticMASTER (green) supported movements (n=5) at 3 sessions. Error bars show
SEM.
Figure 4.21 shows the reachable surface area scores for Armon Edero supported
movements for the dominant arm for all 5 subjects plotted versus time. Figure 4.22
shows the same results for HapticMASTER supported movements. A Shapiro-Wilk test
revealed that the population for time has a significant deviation from normality
(p=0.016). There was no statistically significant relationship between time and reachable
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surface area scores for Armon Edero supported movements for the dominant arm
(Spearman’s Correlation, rs=0.079, p=0.780).

There was no statistically significant

relationship between time and reachable surface area scores for HapticMASTER
supported movements for the dominant arm (Spearman’s Correlation, r s=0.042, p=0.881).

Figure 4.21 Reachable surface area scores for Armon Edero supported movements for
the dominant arm for all 5 subjects versus time.
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Figure 4.22 Reachable surface area scores for HapticMASTER supported movements for
the dominant arm for all 5 subjects versus time.
Figure 4.23 shows the reachable surface area scores for Armon Edero supported
movements for the non-dominant arm for all 5 subjects plotted versus time. Figure 4.24
shows the same results for HapticMASTER supported movements.

There was no

statistically significant relationship between time and reachable surface area scores for
Armon Edero supported movements for the non-dominant arm (Spearman’s Correlation,
rs=0.340, p=0.214). There was no statistically significant relationship between time and
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reachable surface area scores for HapticMASTER supported movements for the nondominant arm (Spearman’s Correlation, rs=-0.018, p=0.948).

Figure 4.23 Reachable surface area scores for Armon Edero supported movements for
the non-dominant arm for all 5 subjects versus time.
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Figure 4.24 Reachable surface area scores for HapticMASTER supported movements for
the non-dominant arm for all 5 subjects versus time.
Figure 4.25 shows the vertical AROM for Armon Edero supported movements for
the dominant arm for all 5 subjects plotted versus time. Figure 4.26 shows the same
results for HapticMASTER supported movements. There was no statistically significant
relationship between time and vertical AROM for Armon Edero supported movements
for the dominant arm (Spearman’s Correlation, rs=0.139, p=0.621).
statistically

significant

relationship

between
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time

and

vertical

There was no
AROM

for

HapticMASTER supported movements for the dominant arm (Spearman’s Correlation,
rs=0.077, p=0.785).

Figure 4.25 Vertical AROM for Armon Edero supported movements for the dominant
arm for all 5 subjects versus time.
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Figure 4.26 Vertical AROM for HapticMASTER supported movements for the dominant
arm for all 5 subjects versus time.
Figure 4.27 shows the vertical AROM for Armon Edero supported movements for
the non-dominant arm for all 5 subjects plotted versus time. Figure 4.28 shows the same
results for HapticMASTER supported movements. There was no statistically significant
relationship between time and vertical AROM for Armon Edero supported movements
for the non-dominant arm (Spearman’s Correlation, rs=0.194, p=0.488). There was no
statistically

significant

relationship

between

time

and

vertical

AROM

for

HapticMASTER supported movements for the non-dominant arm (Spearman’s
Correlation, rs=-0.009, p=0.974).
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Figure 4.27 Vertical AROM for Armon Edero supported movements for the nondominant arm for all 5 subjects versus time.
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Figure 4.28 Vertical AROM for HapticMASTER supported movements for the nondominant arm for all 5 subjects versus time.
Figure 4.29 shows the subject-reported visual analog scale exertion level scores
for Armon Edero supported movements for all 5 subjects plotted versus time. Figure
4.30 shows the same results for HapticMASTER supported movements. There was no
statistically significant relationship between time and subject-reported exertion level
scores for Armon Edero supported movements (Spearman’s Correlation, r s=0.193,
p=0.491). There was no statistically significant relationship between time and subjectreported exertion level scores for HapticMASTER supported movements (Spearman’s
Correlation, rs=-0.413, p=0.126).
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Figure 4.29 Subject-reported visual analog scale exertion level scores for Armon Edero
supported movements for all 5 subjects versus time.
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Figure 4.30 Subject-reported visual analog scale exertion level scores for
HapticMASTER supported movements for all 5 subjects versus time.
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Figure 4.31 shows the MVIC results for the dominant elbow for each of the 5
subjects and the control subject across 3 sessions.

Figure 4.32 shows the MVIC results

for the non-dominant elbow for each of the 5 subjects and the control subject across 3
sessions. Elbow MVIC results are for the following movements: elbow flexion, elbow
extension, elbow external rotation, and elbow internal rotation.

Figure 4.31 Dominant elbow MVIC results for each of the 5 subjects and 1 control
subject with DMD across 3 sessions.
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Figure 4.32 Non-dominant elbow MVIC results for each of the 5 subjects and 1 control
subject with DMD across 3 sessions.
Figure 4.33 shows the MVIC results for the dominant shoulder for each of the 5
subjects and the control subject across 3 sessions. Figure 4.34 shows the MVIC results
for the non-dominant shoulder for each of the 5 subjects and the control subject across 3
sessions. Shoulder MVIC results are for the following movements: shoulder abduction,
shoulder adduction, shoulder flexion, and shoulder extension.
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Figure 4.33 Dominant shoulder MVIC results for each of the 5 subjects and 1 control
subject with DMD across 3 sessions.

Figure 4.34 Non-dominant shoulder MVIC results for each of the 5 subjects and 1
control subject with DMD across 3 sessions.
Figure 4.35 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
abduction MVIC for the dominant arm. A Shapiro-Wilk test revealed that the population
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for for dominant abduction MVIC has a significant deviation from normality (p=0.043).
There was no significant relationship between dominant shoulder abduction MVIC and
Armon Edero and supported reachable surface area scores for the dominant arm
(Spearman’s Correlation, rs=0.503, p=0.056).

There was no significant relationship

between dominant shoulder abduction MVIC and HapticMASTER supported reachable
surface area scores for the dominant arm (Spearman’s Correlation, r s=0.416, p=0.123).
There was a significant positive correlation between dominant shoulder abduction MVIC
and Armon Edero supported vertical AROM for the dominant arm (Spearman’s
Correlation, rs=0.711, p=0.003).

There was also a significant positive correlation

between dominant shoulder abduction MVIC and HapticMASTER supported vertical
AROM for the dominant arm (Spearman’s Correlation, rs=0.518, p=0.048).
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Figure 4.35 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder abduction
MVIC for the dominant arm.
Figure 4.36 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
adduction MVIC for the dominant arm. A Shapiro-Wilk test revealed that the population
for dominant shoulder adduction MVIC is approximately normal (p=0.578). A ShapiroWilk test also revealed that the population for reachable surface area and vertical AROM
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for Armon Edero and HapticMASTER supported movements for the dominant arm were
approximately normal (p=0.467, p=0.130, p=0.175, p=0.094). There was no significant
relationship between shoulder adduction MVIC and Armon Edero supported reachable
surface area for the dominant arm (Pearson’s r, r=0.356, p=0.193).

There was no

significant relationship between shoulder adduction MVIC and HapticMASTER
supported reachable surface area for the dominant arm (Person’s r, r=0.346, p=0.206).
There was a significant positive correlation between shoulder adduction MVIC and
Armon Edero vertical AROM for the dominant arm (Perons’ r, r=0.595, p=0.019). There
was also a significant positive correlation between shoulder adduction MVIC and
HapticMASTER supported vertical AROM for the dominant arm (Person’s r, r=0.519,
p=0.047).
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Figure 4.36 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder adduction
MVIC for the dominant arm.
Figure 4.37 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder flexion
MVIC for the dominant arm. A Shapiro-Wilk test revealed that the population for MVIC
for dominant flexion has a significant deviation from normality (p=0.043). There was no
significant relationship between dominant shoulder flexion and Armon Edero and
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supported reachable surface area scores (Spearman’s Correlation, rs=0.430, p=0.110).
There was no significant relationship between dominant shoulder flexion MVIC and
HapticMASTER supported reachable surface area scores (Spearman’s Correlation,
rs=0.422, p=0.117).

There was a significant positive correlation between dominant

shoulder flexion MVIC and Armon Edero supported vertical AROM (Spearman’s
Correlation, rs=0.789, p<0.000). There was no significant correlation between dominant
shoulder flexion MVIC and HapticMASTER supported vertical AROM (Spearman’s
Correlation, rs=0.493, p=0.062).
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Figure 4.37 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder flexion
MVIC for the dominant arm.
Figure 4.38 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
extension MVIC for the dominant arm. A Shapiro-Wilk test revealed that the population
for dominant shoulder extension MVIC is approximately normal (p=0.069). There was a
significant positive correlation between shoulder extension MVIC and Armon Edero
supported reachable surface area for the dominant arm (Persons’ r, r=0.583, p=0.023).
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There was no significant relationship between shoulder extension MVIC and
HapticMASTER supported reachable surface area for the dominant arm (Person’s r,
r=0.453, p=0.090).

There was a significant positive correlation between shoulder

extension MVIC and Armon Edero supported vertical AROM for the dominant arm
(Person’s r, r=0.637, p=0.011). There was also a significant positive correlation between
shoulder extension MVIC and HapticMASTER supported vertical AROM for the
dominant arm (Person’s r, r=0.620, p=0.014).
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Figure 4.38 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder extension
MVIC for the dominant arm.
Figure 4.39 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
abduction MVIC for the non-dominant arm.

A Shapiro-Wilk test revealed that the

population for non-dominant shoulder abduction MVIC is approximately normal
(p=0.211). A Shapiro-Wilk test also revealed that the population for reachable surface
area and vertical AROM for Armon Edero and HapticMASTER supported movements
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for the non-dominant arm were approximately normal (p=0.205, p=0.562, p=0.280,
p=0.160).

There was a significant positive correlation between shoulder abduction

MVIC and Armon Edero supported reachable surface area for the non-dominant arm
(Person’s r, r=0.586, p=0.022). There was no significant relationship between shoulder
abduction MVIC and HapticMASTER supported reachable surface area for the nondominant arm (Persons’s r, r=0.478, p=0.072).

There was a significant positive

correlation between shoulder abduction MVIC and Armon Edero supported vertical
AROM for the non-dominant arm (Person’s r, r=0.651, p=0.009). There was also a
significant positive correlation between shoulder abduction MVIC and HapticMASTER
supported vertical AROM for the non-dominant arm (Person’s r, r=0.585, p=0.022).
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Figure 4.39 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder abduction
MVIC for the non-dominant arm.
Figure 4.40 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
adduction MVIC for the non-dominant arm.

A Shapiro-Wilk test revealed that the

population for non-dominant shoulder adduction MVIC is approximately normal
(p=0.130).

There was a significant positive correlation between shoulder adduction

MVIC and Armon Edero supported reachable surface area for the non-dominant arm
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(Persons’ r, r=0.582, p=0.023). There was a significant positive correlation between
shoulder adduction MVIC and HapticMASTER supported reachable surface area for the
non-dominant arm (Person’s r, r=0.629, p=0.012).

There was a significant positive

correlation between shoulder adduction MVIC and Armon Edero supported vertical
AROM for the non-dominant arm (Person’s r, r=0.642, p=0.010). There was also a
significant positive correlation between shoulder adduction MVIC and HapticMASTER
supported vertical AROM for the non-dominant arm (Person’s r, r=.699, p=0.004).
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Figure 4.40 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder adduction
MVIC for the non-dominant arm.
Figure 4.41 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder flexion
MVIC for the non-dominant arm. A Shapiro-Wilk test revealed that the population for
non-dominant shoulder flexion MVIC is approximately normal (p=0.290). There was no
significant relationship between shoulder flexion MVIC and Armon Edero supported
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reachable surface area for the non-dominant arm (Person’s r, r=0.334, p=0.223). There
was a significant positive correlation between shoulder flexion MVIC and
HapticMASTER supported reachable surface area for the non-dominant arm (Person’s r,
r=0.562, p=0.029). There was a significant positive correlation between shoulder flexion
MVIC and Armon Edero supported vertical AROM for the non-dominant arm (Person’s
r, r=0.587, p=0.021). There was also a significant positive correlation between shoulder
flexion MVIC and HapticMASTER supported vertical AROM for the non-dominant arm
(Person’s r, r=0.717, p=0.003).
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Figure 4.41 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder flexion
MVIC for the non-dominant arm.
Figure 4.42 shows the reachable surface area and vertical AROM results for
Armon Edero and HapticMASTER supported movements plotted versus shoulder
extension MVIC for the non-dominant arm.

A Shapiro-Wilk test revealed that the

population for MVIC for non-dominant shoulder extension has a significant deviation
from normality (p=0.050). There was no significant relationship between non-dominant
shoulder extension MVIC and Armon Edero and supported reachable surface area scores
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(Spearman’s Correlation, rs=0.513, p=0.051). There was a significant positive correlation
between non-dominant shoulder extension MVIC and HapticMASTER supported
reachable surface area scores (Spearman’s Correlation, rs=0.586, p=0.022). There was no
significant relationship between non-dominant shoulder extension MVIC and Armon
Edero supported vertical AROM (Spearman’s Correlation, r s=0.456, p=0.088). There
was no significant correlation between non-dominant shoulder extension MVIC and
HapticMASTER supported vertical AROM (Spearman’s Correlation, r s=0.493, p=0.062).
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Figure 4.42 Reachable surface area for Armon Edero (upper left) and HapticMASTER
supported movements (upper right) and vertical AROM for Armon Edero (lower left) and
HapticMASTER (lower right) supported movements plotted versus shoulder extension
MVIC for the non-dominant arm.

4.8 Sub Aim 2.2 Discussion
The results of this sub-aim track the changes in upper extremity AROM of 5 subjects
with DMD when the arms are supported by the HapticMASTER and by the Armon Edero
passive arm support over the course of 3 sessions. These three sessions occurred over 9
months to 1 year, depending on the subject. The results show that the mean reachable
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surface area scores for HapticMASTER supported movements were greater at every
session than the mean reachable surface area scores for Armon Edero supported
movements for the dominant and the non-dominant arms. The results also show that the
mean vertical AROM was greater for HapticMASTER supported movements at every
session compared to Armon Edero supported movements for the dominant and the nondominant arms. These results support the hypothesis that admittance control provides
individuals with DMD increased AROM compared to a commercially available passive
arm support due to the benefits of admittance control. However, these differences were
not statistically significant. Additionally, the reachable surface area scores and vertical
AROM did not decrease over time as expected. These results can be explained by the
limited number of subjects included in this study and the variability in progressive loss of
muscle strength in DMD. The progressive upper extremity functional loss associated
with DMD is highly variable from individual to individual and can depend on secondary
factors such as disuse atrophy and contractures. For this reason, a large sample size may
be necessary to see statistically significant differences in HapticMASTER and Armon
Edero supported AROM over multiple sessions. However, due to the small population of
individuals with DMD and limited number of those individuals willing to participate in a
longitudinal study requiring multiple visits prevented a study of this nature. In addition,
due to the variability in progressive loss of upper extremity function, it is possible that
results would demonstrate decreasing AROM over time for Armon Edero and
HapticMASTER supported movements if the study were conducted over multiple years
instead of over a single year. Based on the results of this study, 9-12 months is not a
sufficient amount of time to see statistically significant changes in AROM over time.
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This is further substantiated by the passive and unsupported reachable surface area data,
as these results did not demonstrate a trend of decreased upper extremity function or
increased development of contractures for all subjects over the course of 3 sessions.
The mean subject-reported exertion level scores were smaller for the
HapticMASTER compared to the Armon Edero for every session, indicated greater ease
of movement provided by the HapticMASTER robot. The mean Armon Edero exertion
level scores increased with session number indicating an increase in effort required to
generate movements with the Armon Edero over time.

Conversely, the mean

HapticMASTER exertion level scores decreased with session number indicating a
perceived decrease in effort required to generate movements with the HapticMASTER
over time. These results support the hypothesis that the difference between the ease of
movement provided by the HapticMASTER compared to the Armon Edero will increase
over time as an individual loses muscle strength. However, these differences and trends
were not statistically significant. It is expected that a study with a larger sample size
conducted over a longer period of time may reveal statistically significant results;
however, the small sample size and limited number of individuals willing to participate
in a long-term study prevented a study of this nature.
There were no statistically significant correlations between time and reachable
surface area scores, vertical AROM, or subject-reported exertion level scores. These
results can be explained by the relatively short duration of the longitudinal study (9-12
months) given the variability associated with loss of upper extremity function in
individuals with DMD. It is expected that a study run for multiple years may reveal
correlations between HapticMASTER and Armon Edero reachable surface area scores,
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vertical AROM, and exertion level scores.

An additional limitation of this study

regarding study duration and individuals sessions was the difference in timing of sessions
from subject to subjects. It was originally intended that data collection sessions would
occur at the same intervals for each subject; however, scheduling conflicts of the subjects
and their families and the distance some subjects had to travel to the laboratory caused
differences in timing for data collection sessions.

Future studies could avoid this

limitation, and potentially provide motivation for additional subjects to enroll in a study,
by having the researchers travel to the subjects’ homes instead of conducting the data
collection in the laboratory.
Dominant shoulder abduction MVIC and dominant shoulder adduction were both
positively correlated with Armon Edero and HapticMASTER supported vertical AROM.
Dominant shoulder flexion was positively correlated with Armon Edero supported
vertical AROM. Dominant shoulder extension MVIC was positively correlated with
Armon Edero supported reachable surface area scores and HapticMASTER supported
vertical AROM. Non-dominant shoulder abduction MVIC was positively correlated with
Armon Edero supported reachable surface area scores and Armon Edero and
HapticMASTER supported vertical AROM. Non-dominant shoulder adduction MVIC
was positively correlated with Armon Edero and HapticMASTER supported reachable
surface area scores and vertical AROM. Non-dominant shoulder flexion MVIC was
positively correlated with HapticMASTER supported reachable surface area scores and
Armon Edero and HapticMASTER vertical AROM.

And, non-dominant shoulder

extension was positively correlated with HapticMASTER supported reachable surface
area scores.

For the remaining MVIC values, there was no statistically significant
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correlation with reachable surface area scores or vertical AROM. It was expected that
all AROM outcome measures would be positively correlated with shoulder MVIC scores
given the dependence of upper extremity AROM on upper extremity strength. The fact
that this trend was not seen for all outcome measures can be explained by the limitations
observed during data collection of MVIC. Subjects were instructed to make the force
sensor resisted movements with their arm and avoid compensatory movements including
movement of the torso and swinging of the arm.

Additionally, when making the

reachable workspace movements with the Armon Edero and the HapticMASTER,
subjects were instructed to only move their arm and restrict compensatory movements.
However, despite being instructed to avoid compensatory movements, many of the
subjects found it difficult or impossible to avoid such movements. This is likely to due
the fact that these individuals regularly use compensatory movements for activities of
daily living due to limited upper extremity muscle strength and have difficultly deviating
from this convention. Even more, it was observed that subjects were motivated by the
tasks and outcome measures in this study and tended to resort to the use of compensatory
movements to achieve a maximum AROM and/or larger MVIC.

The use of

compensatory movements leads to variability in results as they prevent measurements
from being truly representative of upper extremity function.
An additional limitation of this study was the daily changes in upper extremity
function. A number of subjects stated that their upper extremity strength and energy
level changes significantly from day to day. Given that this study was conducted over the
course of 9-12 months, functional changes due to the progression of DMD may not be
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detectible in the presence of daily changes in function. It is expected that more frequent
data collection sessions over the course of multiple years would reduce this limitation.
Finally, the results from this sub-aim showed no significant decrease in AROM
for HapticMASTER or Armon Edero supported movements with session number or with
time. These results indicate that a period of 9-12 months is not a sufficient amount of
time to observe a decrease in the AROM provided by either arm support. These results
are promising given the progressive nature of DMD. They indicate that progressive loss
of muscle strength over the course of about 1 year will not render either device
significantly less useful in terms of the increase in function they provide compared to
unsupported movements. This is a positive outcome as it indicates that an arm support or
exoskeleton for individuals with DMD has the potential to be a viable commercial
product given that progressive loss over 1 year does not render either device less useful.
Future studies will evaluate the length of time in which either device would no longer
provide a statistically similar increase in function.
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CHAPTER 5
AIM 3: ADMITTANCE CONTROL TO INCREASE INDEPENDENCE

5.1 Sub Aim 3.1 Methods
The objective of this sub aim was to establish user-defined priority tasks based on tasks
they have difficulty performing or cannot perform independently due to upper extremity
functional deficits and would consider most important to be able to perform while using
an upper extremity assistive device. Subjects were asked to report these priority tasks
based on their individual daily living needs and current upper extremity functional
limitations. In addition, subjects were asked to weight each priority task based on
importance, using the values and corresponding importance listed in Table 5.7.
Table 5.1 Weighting Scale for Importance
Weight
0
1
2
3

Importance
Not at all important
A little important
Moderately important
Very important

Source: [51]

Subjects were be recruited for this study though the Parent Project Muscular
Dystrophy DuchenneConnect registry and the Muscular Dystrophy Association. Subjects
will be included in the study based on the following criteria: DMD diagnosis, inability to
raise their hands to their mouth or difficulty doing so while holding a weighted object but
some residual hand function (Brooke scale score of 4 or 5), and no presence of
comorbidities affecting the upper extremities.
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5.2 Sub Aim 3.1 Expected Results
It is expected that the subjects will report priority tasks that reflect an objective of
independently performing activities of daily living such as feeding themselves, drinking
and using a computer and tasks reflecting individual interests and hobbies.

5.3 Sub Aim 3.1 Results
Seven subjects with DMD who met the inclusion and exclusion criteria for this sub aim
were enrolled in the study. Table 5.2 shows the age of each subject, handedness, and
baseline scores of passive reachable surface area and unsupported reachable surface area
for the left and right arms.
Table 5.2 Subjects Enrolled in Aim 3.1 and 3.2
Subject
1c
2c
3c
4c
5c
6c
7c

Age
26
21
15
14
26
27
11

Hand Dominance

Passive RSA
Unsupported RSA
Right
Left
Right
Left
Right
0.713
0.321
0.100
0.032
Right
0.403
0.184
0.007
0.000
Right
0.437
0.470
0.420
0.275
Right
0.488
0.296
0.000
0.000
Right
0.524
0.227
0.001
0.000
Right
0.435
0.709
0.000
0.000
Right
0.628
0.598
0.033
0.013

Figure 5.1 shows a histogram of all of the upper extremity priority tasks named by
the 7 subjects. In total, 45 upper extremity priority tasks were named by the 7 subjects.
Eating independently was a priority task named by every subject.

Drinking,

itching/scratching the head, face, and nose, and petting a cat or dog were tall tasks named
by 5 subjects. Using a phone and using a computer were tasks named by 4 subjects.
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Three subjects named brushing teeth, opening doors, adjusting glasses, picking up
objects, and using a video game controller.

Figure 5.1 The frequency of each upper extremity priority task named by 7 subjects.
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Figure 5.2 shows the mean weight of each priority tasks according to Table 5.1.
Twenty-one of the priority tasks had a mean weight of 3, meaning that the task is very
important. Forty-one of the tasks had a mean weight of 2 or above, meaning that 91% of
the tasks named were rated to have at least moderate importance. Brushing teeth, playing
ping pong, playing an instrument, and adjusting a hat were the only tasks with a mean
importance score of less than 2; however, all of these tasks had a score of at least 1,
meaning they were at least “a little” important to the subjects that named the task.
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Figure 5.2 The mean weight of each upper extremity priority task.
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5.4 Sub Aim 3.1 Discussion
This sub-aim allowed for the identification of user-defined priority tasks based on tasks
these individuals have difficulty performing or cannot perform independently due to
upper extremity functional deficits and would consider most important to be able to
perform while using an upper extremity assistive device. The results of this aim support
the hypothesis that individuals with DMD who have limited upper extremity function
have priority tasks based on activities of daily living and individual interests and hobbies.
Eating independently and drinking were among the most commonly named
priority tasks.

This can be explained by the frequency of meals and the assumed

intrusiveness and burden associated with needing to be fed by a family member, friend,
or personal care attendant. Itching/scratching was also a commonly named task, with
those naming it specifically identifying the head and nose as areas that are difficult to
reach. This is explained by the fact that scratching the head and face is made difficult or
impossible

when

individuals

with

DMD

lose

anti-gravity

strength.

And,

itching/scratching is a task that can be considered intrusive and even uncomfortable if
needed to be performed by a caretaker. There were also a number of tasks identified that
reflect individual interests and hobbies such as playing sports or petting animals. Two
subjects even named a task they had never performed but would be interested in trying if
they had the ability: playing a musical instrument. This indicates that priority tasks can
be born out of interest as much as they can be born out of necessity. All of the priority
tasks had an average weight of 2 or more (indicating an importance level of moderately
or very important) with the exception of putting on a hat, playing an instrument, playing
ping pong, and brushing teeth. This indicates that personal care tasks are not necessarily
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considered more important than hobbies and work-related tasks. It follows that an upper
extremity assistive device should allow for increased independence in activities of daily
living relating to hygiene and personal care as well as personal interests and hobbies.

5.5 Sub Aim 3.2 Methods
The objective of this sub-aim is to determine whether the use of an admittance control
motorized arm support will allow for improvements in independence while performing
priority tasks by having users evaluate their experiences doing so. The priority tasks
identified in sub aim 3.1 that could be reproduced in the laboratory were set up for the
subjects to attempt unsupported. The users qualitatively evaluated their limitations. The
subject’s dominant arm was then be supported by the HapticMASTER, with the gravity
compensation adjusted to the needs of each subject and the subject re-attempted their
priority tasks while supported.
Goal attainment scaling (GAS) was used to allow subjects to quantify the
achievement of priority tasks while supported by the HapticMASTER compared to while
unsupported. GAS provides a quantitative method of rating the extent to which subjects
can perform their priority tasks, allowing for statistical analysis. GAS allows for the
scoring of individualized, weighted tasks and has been shown to be a good measure of
outcome that is sensitive to clinical changes in goal achievement [51]. Execution of each
priority tasks was individually rated on a 5-point scale, based on the GAS scoring
algorithm in Figure 5.3, modified from [51]. Positive scores denote the ability to perform
the task better while supported by the HapticMASTER robot compared to while
unsupported, negative scores denote worse performing while supported by the
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HapticMASTER compared to while unsupported, and a score of 0 denotes no change in
performance while supported by the HapticMASTER compared to while unsupported.
Baseline scores were determined according to the subject’s ability to perform each
priority task while the arms were unsupported. The overall GAS score for each subject
was computed using Equation 5.1, where W i is the weight assigned to the i-the goal and
Xi is the numerical value achieved of the i-th goal based on the GAS algorithm. Overall
GAS scores of greater than 50 mean that overall, taking into account the importance of
each priority task, the subject could perform their priority tasks better while supported by
the HapticMASTER compared to while unsupported. Overall GAS scores of less than 50
mean that overall, taking into account the importance of each priority task, the subject
performed their priority tasks worse while supported by the HapticMASTER compared to
while unsupported.
(5.1)
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Figure 5.3 Algorithm for determining GAS score.
Source: Adapted from [51]
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Subjects were also asked to fill out a self-assessment survey (see Appendix A)
similar to the VAS scale in aim 2 to rate their exertion level while performing each
priority tasks unsupported and while supported by the HapticMASTER robot.

The

subject-reported exertion level scores were averaged for each subject. A Shapiro-Wilk
test was used to determine if the population of mean subject-reported exertion level
scores was approximately normal. If the scores were approximately normal, a paired–
samples t-test was used to determine whether the HapticMASTER required less effort to
perform priority tasks compared to while unsupported. If the difference scores violated
the assumption of normality, a Wilcoxon signed-ranks test was used. SPSS was used for
all statistical analyses.

5.6 Sub Aim 3.2 Expected Results
Due to the benefits of admittance control, it is expected that subjects will be able to
successfully perform their priority tasks while the dominant arm is supported by the
HapticMASTER robot and that successful achievement will be reflected in GAS scores
of +1 or +2 and overall GAS scores of greater than 50.

Subjects are expected to

experience greater ease of execution of priority tasks and decreased effort required while
supported by the HapticMASTER compared to unsupported movements. For tasks that
require bimanual manipulation, some difficulty in performance is expected as only one
arm will be supported by the HapticMASTER robot.
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5.7 Sub Aim 3.2 Results
Seven subjects with DMD who met the inclusion and exclusion criteria for this aim were
enrolled in the study. Table 5.3 shows the age of each subject, handedness, and baseline
scores of passive reachable surface area and unsupported reachable surface area for the
left and right arms.
Table 5.3 Subjects Enrolled in Aim 3.2
Subject
1c
2c
3c
4c
5c
6c
7c

Age
26
21
15
14
26
27
11

Hand Dominance

Passive RSA
Unsupported RSA
Right
Left
Right
Left
Right
0.713
0.321
0.100
0.032
Right
0.403
0.184
0.007
0.000
Right
0.437
0.470
0.420
0.275
Right
0.488
0.296
0.000
0.000
Right
0.524
0.227
0.001
0.000
Right
0.435
0.709
0.000
0.000
Right
0.628
0.598
0.033
0.013

Figure 5.4 shows a boxplot of the GAS scores for all 7 subjects. The mean GAS
score was 63 (SD 6). The minimum GAS score was 55 and the maximum GAS score
was 73. All GAS scores were greater than 50.
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Figure 5.4 Boxplot of GAS Scores for 7 subjects.
Figure 5.5 shows the mean VAS subject-reported exertion level scores while
performing their priority tasks unsupported and while supported by the HapticMASTER.
A Shapiro-Wilk test revealed that the self-reported exertion level scores have no
significant deviation from normality (p=0.734).

The HapticMASTER resulted in a

statistically significant decrease in self-reported exertion levels while performing priority
tasks compared to performing the same tasks while unsupported (paired-samples t-test,
t(7)=4.51, p=0.003, r2=0.74).

An r2=0.74 denotes a large effect size of the
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HapticMASTER on the self-reported exertion level scores while performing priority tasks
compared to performing the same tasks while unsupported.

*

Figure 5.5 Mean subject-reported exertion level scores for unsupported and
HapticMASTER supported performance of priority tasks. Error bars show SEM.
Asterisk denotes statistical significance between groups (p<0.05).

5.8 Sub Aim 3.2 Discussion
This sub-aim investigated the feasibility of using an admittance control motorized arm
support to provide individuals with DMD increased independence performing priority
tasks. The results of the study support the hypothesis that an admittance control arm
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support allowed individuals with DMD to successfully perform their priority tasks
compared to when they were unsupported, as indicated by overall GAS scores of greater
than 50.

Furthermore, subjects reported decreased exertion level scores required to

perform the priority tasks while supported by the admittance control robot compared to
unsupported movements.

These results are explained by the benefits of admittance

control, especially the support against gravity that is provided in order to offload the arm
and the intuitive control and ease of movement provided by minimization of inertia and
friction.
Subjects who had more significantly limited upper extremity strength exhibited
smaller GAS scores and greater exertion level scores. The HapticMASTER virtual mass
inertia value was set to 6kg. Inertia values lower than 6kg resulted in an unstable system
in which the robot vibrated or oscillated and would have been unsafe for user-robot
interaction. This means that the subjects were opposed by the inertia of a 6kg point mass
when they were performing their priority tasks. Therefore, the robot requires a degree of
muscle strength to generate movements despite the minimization of inertia and friction
and support against gravity. As a result, those with more limited muscle strength will
have increased difficulty performing a task even if it is easier than when unsupported. It
is expected that an admittance control arm support with capabilities of further minimizing
the inertia value will result in greater overall GAS scores and smaller exertion level
scores.
The HapticMASTER robot has 3 translational, motorized DOFs operating under
admittance control. It also has a rotation DOF operating passively (yaw). However, two
rotational DOFs (roll and pitch) are fixed. Therefore, the subjects could not rotate their

134

arm in 2 DOFs while performing their priority tasks. This posed a difficulty for the
performance of some tasks that required rotation, such as drinking from a cup without a
straw, a task that requires roll of the forearm. It is hypothesized that an admittance
control arm support that has 6 DOFs (3 motorized translational DOFs and 3 motorized or
passive DOFs) will allow for increased independence in activates of daily living for tasks
that require or benefit from the ability to generate rotational movements.
Individuals with DMD who have significantly limited upper extremity strength
typically have contractures that limit passive range of motion due to lack of active
stretching of the joints. It was observed in this study that individuals who had significant
contractures had difficulty performing priority tasks that requires range of motion beyond
that of their PROM abilities. It is hypothesized that early integration of an admittance
control arm support could reduce the development of contractures by promoting regular
use and active stretching of the arms.
In addition to the limitations imposed by contractures, the ability to perform
priority tasks while supported by the HapticMASTER robot was further hindered by the
inability for some subjects to overcome the set-point of their arm. For example, while
supported by the robot, some of the subjects with more significant muscle weakness were
unable to keep their arm close to the mouth while attempting to eat independently. These
subjects were unable to overcome the natural tendency for their arm to come to a neutral
posture and had to utilize compensatory movements, such as swinging the arm and
movement of the torso and head, in order to get food to their mouth. It is proposed that a
future study could involve the mapping of the distribution of forces resulting from the
arm’s natural set-point. Doing so would allow for the integration of a counteracting
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force-field into the admittance control loop that will minimize the force required by the
user to make movements that deviate from the neutral arm posture.
A limitation of this study was the fact that a single HapticMASTER robot was
used; therefore, only the dominant arm could be supported. As a result, bimanual tasks
were more difficult or not possible to perform, especially for those with more limited
muscle strength. If two robots were available and both arms could be supported, this
study would be hypothesized to further substantiate the benefits of admittance control by
showing greater GAS scores and smaller exertion level scores, especially for tasks that
require or could benefit from the use of both arms.
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CHAPTER 6
AIM 4: DESIGN OF AN ADMITTANCE CONTROL ARM SUPPORT

6.1 Sub Aim 4.1 Methods
6.1.1 Mechanical Design
The phase 1 prototype, pictured in Figure 6.1, uses the Armon Edero 5 DOF passive arm
support as the base. This passive device has low-friction joints and an adjustable spring to
provide support against gravity. Robotis MX Series Dynamixel Smart Servo motors were
mounted to control the angular position of each of the 6 joints. A 6 DOF ATI Industrial
Automation force/torque sensor was mounted under the forearm cuff to sense the user’s
applied force in the x, y, and z directions and applied torque in the pitch and yaw
directions. The custom motor mounts, gears, force sensor mounts, and forearm cuff were
designed using Pro/ENGINEER and Creo Parametric 3.0 CAD Software by PTC and
fabricated using a Flashforge Creator Pro 3D Printer.
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Figure 6.1 The 5 DOF Armon Edero retrofit with motors and force/torque sensor to
operate under admittance control in all DOFs.

6.1.2 Control Algorithm
Figure 6.2 shows the control loop implemented in MATLAB to control the position and
orientation of the motorized Armon Edero based on the user’s applied force and torque.
The user’s applied force and torque is sensed by the 6 DOF force/torque sensor. The x, y,
and z forces are divided by a virtual mass of 0.05kg. The resulting acceleration is
integrated twice using CVode, an ordinary differential equation solver developed at
Eindhoven University [52], to calculate the position to which the virtual mass would
move under the user’s applied force and specified damping. The x and z torques are
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divided by the moment of inertia of a 0.05kg point mass. The resulting angular
acceleration is integrated twice using CVode [52] to calculate the angle to which the
virtual mass would rotate under the user’s applied torque and specified damping.
The damping coefficients were determined empirically in order to keep the
system stable while minimizing the force opposing the user’s movement. The damping
coefficients were set to 10N*sec/m in the x and y directions, 12N*sec/m in the z
direction, and 25Nm*sec/rad in the yaw and pitch directions. These values are multiplied
by the calculated velocity and subtracted from the user’s applied force and torque for
each iteration of the admittance control loop.

Figure 6.2 The control loop utilizing admittance control (red) to control the position and
orientation of the exoskeleton (gray).
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The desired position and orientation of the exoskeleton end effector, or forearm
cuff, calculated by the admittance control loop is checked for whether it satisfies
boundary conditions at each iteration of the control loop, and if not, the position and
orientation is reset accordingly. Custom inverse kinematics calculates the six joint angles
required to achieve the desired end effector position and orientation. Equations 6.1-6.4
show the inverse kinematics equations used to calculate the joint angles (
5)

1,

2,

3,

and

required to achieve the desired end-effector position (x, y, and z) based on the link

lengths of the Armon Edero (l1, l2, l3, and l5). The angles of joints 4 and 6 (

4

and

6),

controlling the orientation of the end-effector, were determined directly from the control
algorithm based on the user’s applied torque. The resulting joint angles are converted to
motor positions and used to control the angle of each Dynamixel motor to translate and
orient the forearm cuff (and the user’s arm) to the desired position and orientation for
each iteration of the control loop based on the applied force and torque. As a result, the
user is intuitively controlling the motion of the forearm cuff in while only being opposed
by the inertia of the 0.5kg virtual mass and the specified damping required to keep the
system stable.
(6.1)

(6.2)
(6.3)
(6.4)
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Assistance against gravity is achieved by calibrating the force/torque sensor while
the user’s arm is at rest in the forearm cuff. Doing so provides the user with an upward
force equal and opposite to the force of gravity that is acting on the user’s arm during the
calibration of the sensor.
6.1.3 Prototype Improvements
A number of advancements were made to the initial prototype, including control
algorithm optimization and hardware improvements in order to enhance the user-robot
interaction. The phase 2 prototype is pictured in Figure 6.3.

Figure 6.3 The phase 2 prototype of the multi-DOF Armon Edero retrofit with motors
and force sensor to operate under admittance control in 3 DOFs.
The mechanical design of the prototype was improved by eliminating the gears at
joints 1, 2, and 3 that control the x and y position of the end effector. By attaching the
motor horns so that they directly drive the joint instead of using gears eliminates the
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backlash, or play, that can propagate motor error to end effector position error. The ATI
force/torque sensor used in the phase 1 prototype was replaced with an Optoforce 200N
3DOF force sensor to improve the input force signal. This sensor was chosen because it
has a capacity and resolution more appropriate for human interaction and does not have
the hysteresis, oscillations, and other signal imperfections that the ATI force sensor does.
Improvements to the control software was made in order to decrease the loop
time. The control software for the phase 1 prototype was run using 32bit MATLAB. The
phase 2 prototype used 64bit MATLAB to allow for larger memory. The return delay
time of the Dynamixel motors was set to 2microseconds to minimize the time per data
value that it takes from the transmission of the instruction packet until the return of the
status packet. The motor baud rate was increased to 2Mbps to maximize the baud rate to
communicate with the controller.

The phase 1 prototype required an instruction packet

to be sent to each motor individually in order to command a desired motor position and to
read a current motor position. The result was a total of 12 instruction packets to read and
write to each motor for each iteration of the control loop. In order to reduce the read and
write times “syncwrite” and “syncread” were used as it allowed for a single instruction
packet to be sent in order to command a desired position to all 6 motors and a single
instruction packet to be sent in order to read the current position from all 6 motors. As a
result, each iteration of the control loop required 2 instruction packets instead of 12.
Because the Armon Edero has a redundant horizontal link (i.e. has 3 links to achieve the
desired x and y position) the inverse kinematics involves solving for an infinite number
of solutions. The phase 1 prototype dealt with the redundancy by limiting the number of
solutions in the range of 90˚ to 270˚ in increments of 0.1˚. The result was 1800 possible
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joint angle solutions to achieve the desired x, y position. This inverse kinematics code
was optimized for the phase 2 prototype by limiting the range of possible solutions to +/5˚ from the previous joint angles in increments of 0.02˚. The result was only 500
possible solutions, 1300 fewer calculations than the phase 1 prototype. Even more,
because of the decreased range, the increments of possible solutions was decreased from
0.1˚ to 0.02˚ to allow for increased resolution. Lastly, the mass and damping values were
tuned to improve the smoothness and ease of movement. The mass was set to 0.25kg and
the damping value to 5 N*sec/m.
6.1.4 Evaluation of Design
In order to evaluate the design of the phase 1 prototype, a user with no disability was
instructed to generate movements with the device in each DOF. The accuracy of the
control algorithm was evaluated by examining the user’s applied force and torque and
comparing the resulting desired position and orientation as calculated by the admittance
control loop to the actual position and orientation achieved by the exoskeleton. The
percent error between the desired end effector position and orientation in each DOF as
calculated by the control loop and the actual end effector position was calculated using
Equation 6.5. The time delay of each iteration of the control loop was determined by
using MATLAB’s “tic” and “toc” functions.
In order to evaluate the design of the phase 2 prototype, a user with no disability
was instructed to generate movements with the device using all 3 DOFs for 10 trials, each
lasting 30 seconds. The average percent error was calculated for each trial in each DOF
and the time delay of each iteration of the control loop and each section of the software
was averaged across each trial.
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(6.5)

6.2 Sub Aim 4.1 Results
Figure 6.4 shows the user’s applied forces for movements in the x, y, and z directions for
using the phase 1 prototype.

The corresponding x, y, and z desired positions as

calculated by the admittance control loop are shown in this Figure with the actual
exoskeleton end-effecotr position following the desired position closely.

Figure 6.5

shows the user’s applied torques for movements in the yaw and pitch directions using the
phase 1 prototype. The corresponding yaw and pitch orientations as calculated by the
admittance control loop are shown in the figure with the actual exoskeleton end-effector
orientation similarly following the desired orientation closely.

Table 6.1 shows the

percent error between the desired and actual position for each of the DOFs for the phase 1
prototype. The mean control loop time was 0.0327seconds.
Table 6.1 Phase 1 Prototype Percent Error Results
DOF
x
y
z
yaw
pitch

Percent Error
1.36%
1.48%
8.06%
1.46%
1.80%
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Figure 6.4 The user’s applied force (black) in the x (top), y (middle), and z directions
(bottom) and the corresponding desired x, y, and z positions computed by the admittance
control algorithm (blue) and actual end effector position (red) for the phase 1 prototype.
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Figure 6.5 The user’s applied torque (black) in the yaw (top) and pitch (bottom)
directions and the corresponding desired yaw and pitch orientations computed by the
admittance control algorithm (blue) and actual end effector orientation (red) for the phase
1 prototype.
Figure 6.6 shows the user’s applied forces for movements in the x, y, and z
directions for using the phase 2 prototype for a single trial. The corresponding x, y, and z
desired positions as calculated by the admittance control loop are shown in this figure
with the actual exoskeleton end-effector position following the desired position closely.
Figure 6.7 shows the control loop time for a single trial. Table 6.2 shows the average
percent error between the desired and actual position for each of the DOFs for the phase 2
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prototype for each of the 10 trials. Table 6.3 shows the average control loop time and the
average time for each section of the software for all 10 trials.

Figure 6.6 The user’s applied force (black) in the x (top), y (middle), and z directions
(bottom) and the corresponding desired x, y, and z positions computed by the admittance
control algorithm (blue) and actual end effector position (red) for the phase 2 prototype.
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Figure 6.7 The time delay of the control loop for 1 trial showing the time to read the
force sensor (blue), the time to solve the ordinary differential equation (red), the time to
perform inverse kinematics calculations (magenta), the time to command the motors
(green), the time to read the current motor positions (cyan), the time to perform forward
kinematics calculations (yellow), and the total runtime of the control loop (black).
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Table 6.2 Phase 2 Prototype Percent Error Results
Trial

x
y
z
0.65%
0.53%
0.96%
1
2
0.82% 0.66% 0.96%
3
0.75% 1.00% 1.60%
4
0.61% 0.96% 1.37%
5
0.68% 1.20% 1.78%
6
0.77% 0.85% 1.71%
7
1.17% 0.90% 2.49%
8
0.86% 0.70% 1.40%
9
0.84% 1.09% 1.53%
10
0.68% 0.68% 1.07%
Average
0.78% 0.85% 1.49%
Standard Deviation 0.16% 0.21% 0.46%
Table 6.3 Phase 2 Prototype Time Delay
Trial
1
2
3
4
5
6
7
8
9
10
Average
Standard
Deviation

Force
Sensor
0.07ms
0.06ms
0.06ms
0.06ms
0.05ms
0.06ms
0.06ms
0.05ms
0.06ms
0.08ms
0.06ms
0.01ms

ODE
Solver
0.13ms
0.12ms
0.13ms
0.11ms
0.11ms
0.12ms
0.12ms
0.11ms
0.11ms
0.13ms
0.12ms
0.01ms

Inverse
Kinematics
3.32ms
3.32ms
3.44ms
3.31ms
3.27ms
3.36ms
3.25ms
3.27ms
3.13ms
2.95ms
3.26ms
0.14ms

Command
Motors
0.85ms
1.01ms
0.78ms
0.97ms
1.05ms
1.10ms
0.77ms
0.95ms
1.01ms
1.16ms
0.97ms
0.13ms
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Read
Motors
2.72ms
2.63ms
2.68ms
2.72ms
2.73ms
2.65ms
2.69ms
2.74ms
2.63ms
2.57ms
2.68ms
0.06ms

Forward Total
Kinematics
0.31ms
7.66ms
0.23ms
7.64ms
0.23ms
7.66ms
0.29ms
7.70ms
0.16ms
7.78ms
0.20ms
7.78ms
0.23ms
7.41ms
0.25ms
7.64ms
0.21ms
7.43ms
0.13ms
7.40ms
0.22ms
7.61ms
0.05ms
0.15ms

6.3 Sub Aim 4.1 Discussion
The prototype presented in this sub-aim demonstrates a novel approach to upper
extremity exoskeleton design. The 5 DOF prototype using the Armon Edero as the base
demonstrated successful implementation of admittance control as the control paradigm
for fully motorizing all DOFs of a commercially available passive arm support. The force
and position plots demonstrate the successful implementation of an intuitive control
paradigm in which the motion of the exoskeleton is based on the magnitude and direction
of the user’s applied force and torque.
Minimization of the control loop time delay is of great importance when
implementing admittance control. Because the motion of the robot is based on the user’s
applied force, any time delay that is significant enough to be perceived by the user will
result in an oscillating, unstable system. In order to ensure stable and comfortable
interaction between the user and the exoskeleton, the control loop should have a
maximum delay of 10ms [53]. Even more, a time delay beyond 10ms can result in the
virtual mass feeling heavier to the user [54]. The HapticMASTER robot, which has an
estimated control loop delay of 10ms, further substantiates this required minimum time
delay [54]. The phase 2 prototype had an average time delay of 7.61ms; however, the
force sensor was set to a maximum frequency of 100Hz. Though the force sensor has
capabilities to operate at up to 1000Hz, the MATLAB code used to operate the
exoskeleton required the frequency to be set at 100Hz. Therefore, the force sensor data
would be quantized at a control loop speed of 7.61ms causing the actual time delay to be
bottlenecked by the force sensor frequency at 10ms.

This 10ms time delay met the

target time delay to ensure optimal interaction between the user and the exoskeleton.
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Further, this time delay was a greater than a 3x improvement compared to the phase 1
prototype. Improvements in the time delay were due to a decrease in DOFs from 5DOF
to 3DOF, the use of 64bit MATLAB, decrease in return delay time of the motors,
increase in motor baud rate, use of “syncread” and “syncwrite” functions, and
optimization of the inverse kinematics code. For the phase 2 prototype, the inverse
kinematics code accounted for the largest portion of the time delay. This runtime of each
iteration of the control loop can be further decreased to improve the responsiveness of the
system by replacing the current MATLAB code with C or C++. Implementing a force
software that allows the force sensor to read at a frequency greater than 100Hz will also
improve the runtime. Improvements beyond 10ms will increase the responsiveness of the
system.
Errors between the desired and actual positions and orientations of the
exoskeleton end effector (forearm cuff) were less than 0.25% for the x and y directions
and less than 0.5% for the z direction for the phase 2 prototype. The error between the
desired and actual position for the phase 2 prototype was almost 1/10 of the error for the
phase 1 prototype for the x and y directions, and almost 1/20 of the error for the z
direction. The improvements in error for the phase 2 prototype can be explained by the
decrease in time delay and use of a force sensor with improved resolution. The error
between the desired and actual position in the z direction is about twice that of the x and
y directions. This is explained by the gear ratio for the joint controlling the z position of
the end effector. The gear ration is about 2, meaning that error between the desired motor
position and actual motor position will be doubled for any given iteration of the control
loop.
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6.4 Sub Aim 4.2 Methods
6.4.1 Mechanical Design
The vertical assist prototype, pictured in Figure 6.8, uses the X-Ar 5 DOF commercially
available passive arm support as the base. This device has low-friction joints and an
adjustable spring housed in a four-bar linkage to provide support against gravity. In order
to demonstrate the modular nature of this design approach, a Dynamixel motor was
mounted to control the position of the four-bar linkage, therefore controlling the elevation
(or z position) of the forearm cuff based on the user’s applied force in the z direction
while the x and y positions and pitch and yaw orientations were left to operate passively.
A 3 DOF Optoforce force sensor was mounted under the forearm cuff to sense the user’s
applied for in the z direction. The custom motor mount, gears, and force sensor mount
were designed using Pro/ENGINEER and fabricated using a Flashforge Creator Pro 3D
Printer.

Figure 6.8 The vertical assist module mounted on the X-Ar to operate vertically under
admittance control while remaining passive in the other DOFs.
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6.4.2 Control Algorithm
The control loop shown in Figure 2 was used to calculate and control the z position of the
forearm cuff based on the user’s applied force in the z direction. Equation 6.4 was used to
calculate the joint angle required to achieve the desired elevation for each iteration of the
control loop. The virtual mass was set to 0.5kg and damping coefficient was set to
25N*sec/m.
6.4.3 Evaluation of Design
The time delay of each iteration of the control loop and the percent error between desired
and actual end effector position was determined for this prototype. A user with no
disability was instructed to generate movements with the device in the positive and
negative vertical direction for 10 trials, each lasting 30 seconds. The average percent
error was calculated for each trial and the time delay of each iteration of the control loop
was averaged across each trial.

6.5 Sub Aim 4.2 Results
Figure 6.9 shows the user’s applied forces for movements in the z direction for using the
vertical assist prototype for a single trial.

The corresponding z desired position as

calculated by the admittance control loop is shown in this figure with the actual
exoskeleton end-effecotr position following the desired position closely. Table 6.4 shows
the average percent error between the desired and actual position for the vertical assist
prototype for each of the 10 trials and the average time for each iteration of the control
loop.
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Figure 6.9 The user’s applied force (left) and the desired z position (right, blue) and
actual z position (right, red) of the exoskeleton end effector for one trial.
Table 6.4 Vertical Assist Prototype Results
Trial

Percent Error Control Loop Time Delay (ms)
1
0.00027%
1.10
2
0.00012%
1.10
3
0.00029%
1.10
4
0.00014%
1.10
5
0.00021%
1.10
6
0.00008%
1.10
7
0.00064%
1.10
8
0.00025%
1.10
9
0.00015%
1.10
10
0.00015%
1.10
Average
0.00023%
1.10
Standard Deviation 0.00016%
0
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6.6 Sub Aim 4.2 Discussion
This sub-aim demonstrated the feasibility of using 3D printing technology to modularly
retrofit a force sensor and motor to a commercially available passive arm support. The
prototype demonstrates this modular approach through the successful implementation of
one motorized DOF while keeping the other DOFs passive. This novel approach has the
potential to allow for customization of an exoskeleton to individuals based on their
capabilities. Individuals with varying degrees of upper extremity function can benefit
from the same device by the addition of motorized DOFs in the form of “assist modules”,
so that the device can be purely passive, purely motorized, or have some subset of the
DOFs motorized. The result is a more compact design in which the device is never
bulkier, more technically complicated, or more expensive than required. Even more, this
modular approach has the potential to be well suited for individuals with DMD who have
changes in functional status over time.
The time delay of the control loop for this prototype was 1.10ms. However, the
force sensor was set to operate at 100Hz. Similar to the Armon Edero prototype, this
means that the force sensor data will be quantized at control loop speeds greater than
10ms. The result is a control loop delay limited to 10ms, which is at the target time delay
to ensure comfortable and stable interaction with the user. The use of a force sensor that
operates at a faster frequency will allow for further reduction in the error between the
desired and actual end effector position.
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CHAPTER 7
CONCLUSION AND FUTURE DIRECTIONS

7.1 Conclusion
This dissertation presented a novel approach to increase upper extremity AROM for
individuals with DMD with the intention of increasing independence in activities of daily
living by using admittance control. The results of these aims support they hypothesis that
a motorized arm support utilizing the admittance control paradigm will provide
individuals with DMD an intuitive and effective means of increasing upper extremity
AROM and an increase in independence in activities of daily living.

Further, the

development work presented in this dissertation demonstrated the successful fabrication
of an admittance control motorized arm support in multiple DOFs and by using a modular
approach. The novel approach presented herein has the potential to help individuals with
DMD maintain self-sufficiency and improve quality of life.

7.2 Future Directions
Disuse atrophy and the development of contractures are known secondary contributors to
loss of upper extremity function for individuals with DMD. Sub-maximal use of residual
muscle strength and stretching of the joints and muscles are prescribed to minimize
disuse atrophy and contractures. If implemented for daily use to assist with activities of
daily living, an admittance control exoskeleton will promote the use of residual muscle
strength and active stretching of the joints and muscles. Therefore, it is hypothesized that
regular use of an admittance control arm support will delay the loss of upper extremity
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function for individuals with DMD by reducing these secondary factors. Future work
will evaluate the delay in upper extremity function over time associated with regular use
of an admittance control arm support.
Future work will also investigate the implementation of additional motorized
DOFs. A fully motorized 7DOF admittance control device (3 translational DOFs, 3
rotational DOFs, and a gripper) will be fabricated and evaluated with individuals with
DMD. Using a modular approach, the researchers can evaluate the importance of each
motorized DOF and identify stages at which each DOF needs to be motorized as upper
extremity function decreases over time.
An ongoing translational study conducted by the researchers in collaboration with
Talem Technologies, funded by Parent Project Muscular Dystrophy (PPMD), will
involve the fabrication and evaluation of a passive arm support with admittance control
implemented in the vertical direction.

Thirty individuals with DMD will receive a

passive arm support developed by Talem Technologies.

Changes in AROM and

independence in activities of daily living while using the arm support will be quantified
compared to unsupported movements. After six months of regular use of the device, a
“vertical assist kit” will be installed on each user’s passive arm support to motorize the
vertical DOF using admittance control.

Changes in AROM and independence in

activities of daily living while using the motorized device will be evaluated and
compared to the purely passive arm support and to unsupported movements.

User

feedback will be collected on a regular basis to ensure that the device design meets user
needs and provides an increase in upper extremity function that outweighs any burden
associated with the use of an assistive device of this nature. At the conclusion of the
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study, design improvements will be implemented based on the result of the study and on
user input with the intention of becoming a commercially available device for individuals
with DMD and other conditions resulting in limited upper extremity muscle strength.
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APPENDIX A
SURVEYS

Self-Assessment Survey for Aim 2
While making the reachable workspace movements with the Armon Edero passive arm
support, please rate the exertion level required for you to complete the movements (mark
your answer on the line):

Least amount of effort

Most amount of effort

While making the reachable workspace movements with the HapticMASTER robot,
please rate the exertion level required for you to complete the movements (mark your
answer on the line):

Least amount of effort

Most amount of effort

Compare your movements with the Armon Edero passive arm support and with the
HapticMASTER robot. Which condition allowed for the easiest movements in the
horizontal direction (mark your answer on the line)?
Armon Edero

HapticMASTER

Compare your movements with the Armon Edero passive arm support and with the
HapticMASTER robot. Which condition allowed for the easiest movements in the
vertical direction (mark your answer on the line)?

Armon Edero

HapticMASTER

Do you have any additional comments regarding your experience with the Armon Edero
and the HapticMASTER robot?
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Self-Assessment Survey for Aim 3.2
While performing your priority task unsupported, please rate the exertion level required
for you to complete the task (mark your answer on the line):

Least amount of effort

Most amount of effort

While performing your priority task while supported by the HapticMASTER robot, please
rate the exertion level required for you to complete the task (mark your answer on the
line):

Least amount of effort

Most amount of effort
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